≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Disorders of iron metabolism

DOID EFO Endpoint Browser PheWeb

E4_IRON_MET

hereditary hemochromatosis type 1: Hemochromatosis type 1 (classic) is the most common form of hereditary hemochromatosis (HH), a group of diseases characterized by excessive tissue iron deposition. Due to its incidence (1/200-1/1000), it is not considered as a rare disease, unlike the other subforms of the disease

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E83.1
  • Hospital discharge: ICD-9 — 2750
  • Cause of death: ICD-10 — E83.1
  • Cause of death: ICD-9 — 2750

2 out of 7 registries used, show all original rules.

646

4. Check minimum number of events

None

646

5. Include endpoints

None

646

6. Filter based on genotype QC (FinnGen only)

614

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E83
Name in latin
Perturbationes metabolismi ferri

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2585 1043 1510
Only index persons 2299 965 1334
Unadjusted period prevalence (%)
Whole population 0.04 0.03 0.04
Only index persons 0.04 0.04 0.05
Median age at first event (years)
Whole population 55.61 56.88 54.60
Only index persons 55.33 56.71 54.33

-FinnGen-

Key figures

All Female Male
Number of individuals 614 293 321
Unadjusted period prevalence (%) 0.13 0.10 0.15
Median age at first event (years) 56.33 55.41 57.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
646
Matched controls
6460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E83.1
ICD-10 Finland
Disorders of iron metabolism
4503599627370496.0
307.7
638
*
TPH00
NOMESCO Finland
Phlebotomy
203.5
142.0
143
9
SPAT1074
SPAT
Venesection
125.0
90.8
96
9
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
12.5
75.7
78
70
TPH00, ,
SPAT
214.9
74.9
76
*
B99
ICPC
Blood/lymph/spleen disease other
120.2
61.1
65
6
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
12.9
58.2
58
49
M14.5*E83.1
ICD-10 Finland
Arthropathy in haemochromatosis
+∞
48.6
46
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
11.2
33.4
36
34
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
33.0
109
318
K76.9
ICD-10 Finland
Liver disease, unspecified
9.5
24.9
30
33
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
10.4
24.9
28
28
B04
ICPC
Blood symptom/complaint
24.1
15.2
21
9
Z31.5
ICD-10 Finland
Genetic counselling
3.5
14.7
52
157
B28
ICPC
Limited function/disability (B)
37.0
14.5
18
5
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
5.8
14.2
26
46
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
16.2
14.0
22
14
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.1
13.9
39
100
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.1
12.5
54
185
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
12.4
155
865
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
11.1
96
464
R53
ICD-10 Finland
Malaise and fatigue
1.9
11.0
160
939
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
10.5
179
1105
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.7
10.3
24
53
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
10.9
9.8
18
17
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
9.8
9.8
19
20
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.1
9.6
98
504
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.3
9.4
24
57
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
9.4
35
109
M14.5
ICD-10 Finland
Arthropathies in other endocrine, nutritional and metabolic disorders
+∞
9.4
9
*
2750A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of iron metabolism[HAEMOCHROMATOSIS]
+∞
9.4
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
8.9
56
234
V03AC03
ATC
deferasirox; oral
+∞
8.3
8
*
R94.5
ICD-10 Finland
Abnormal results of liver function studies
6.8
7.6
18
27
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
10.2
7.6
14
14
D75.1
ICD-10 Finland
Secondary polycythaemia
10.2
7.6
14
14
F41
ICD-10 Finland
Other anxiety disorders
4.3
7.5
19
45
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
7.5
60
280
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.5
142
895
SPAT1377
SPAT
Polysomnography
3.4
7.5
26
78
B74
ICPC
Malignant neoplasm blood other
81.0
7.4
8
*
C03DA01
ATC
spironolactone; oral
2.2
7.4
66
322
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.4
279
2096
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
7.3
7
*
127
Kela drug reimbursment
Transplant complication
6.4
7.3
18
29
G47.3
ICD-10 Finland
Sleep apnoea
1.7
7.2
158
1035
ZXA10
NOMESCO Finland
Bilateral
1.9
7.2
101
581
SPAT1263
SPAT
Sampling
1.6
7.1
246
1808
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.0
82
443
R06.0
ICD-10 Finland
Dyspnoea
1.7
7.0
156
1026
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.0
6.9
74
388
R03AC02
ATC
salbutamol; inhalant
1.5
6.8
337
2672
E86
ICD-10 Finland
Volume depletion
22.8
6.7
9
*
H02AB06
ATC
prednisolone; systemic
1.5
6.7
285
2186
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
7.9
6.6
14
18
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
12.4
6.6
11
9
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
6.5
25
80
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
6.3
67
349
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
9.4
6.3
12
13
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.3
270
2067
E83.0
ICD-10 Finland
Disorders of copper metabolism
+∞
6.3
6
*
L04AA06
ATC
mycophenolic acid; systemic
4.0
6.2
17
43
A02BC02
ATC
pantoprazole; systemic
1.5
6.0
410
3442

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.7e+00
3.9e+00
—
—
4.2e+00
4.1e+00
3.1e+00
cases:9.92%
controls:1.92%
cases:36.59%
controls:1.15%
—
—
—
—
cases:7.48%
controls:0.12%
cases:36.60%
controls:0.96%
cases:41.44%
controls:3.16%
64
124
581
6325
236
74
409
6375
—
—
48
8
594
6426
224
59
388
6100
196
151
277
4627
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.7e+00
4.0e+00
—
—
4.0e+00
4.0e+00
3.0e+00
cases:10.23%
controls:2.05%
cases:39.22%
controls:1.21%
—
—
—
—
cases:7.63%
controls:0.16%
cases:36.60%
controls:1.02%
cases:42.07%
controls:3.54%
66
132
579
6317
253
78
392
6371
—
—
49
10
593
6424
224
63
388
6096
199
169
274
4609
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.6e+00
3.9e+00
—
—
4.0e+00
4.0e+00
3.0e+00
cases:10.70%
controls:2.37%
cases:39.22%
controls:1.24%
—
—
—
—
cases:7.79%
controls:0.16%
cases:37.58%
controls:1.12%
cases:42.07%
controls:3.56%
69
153
576
6296
253
80
392
6369
—
—
50
10
592
6424
230
69
382
6090
199
170
274
4608
Hematology
82 [38004501]
1.2e+00
2.4e+00
3.7e+00
1.0e+50
3.5e+00
2.8e+00
2.5e+00
cases:3.72%
controls:1.13%
cases:5.89%
controls:0.59%
cases:2.95%
controls:0.08%
cases:7.13%
controls:0.00%
cases:4.52%
controls:0.14%
cases:9.48%
controls:0.62%
cases:12.68%
controls:1.17%
24
73
621
6376
38
38
607
6411
19
5
626
6444
46
0
599
6449
29
9
613
6425
58
38
554
6121
60
56
413
4722
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
6.7e-01
2.8e+00
4.5e+00
—
3.1e+00
2.8e+00
2.1e+00
cases:18.45%
controls:10.40%
cases:50.39%
controls:5.63%
cases:37.21%
controls:0.65%
—
—
cases:13.08%
controls:0.70%
cases:51.63%
controls:6.17%
cases:57.72%
controls:14.80%
119
671
526
5778
325
363
320
6086
240
42
405
6407
—
84
45
558
6389
316
380
296
5779
273
707
200
4071
Gastroenterology
10 [38004455]
5.8e-01
1.7e+00
2.5e+00
—
3.6e+00
2.8e+00
1.8e+00
cases:9.77%
controls:5.74%
cases:11.63%
controls:2.36%
cases:3.57%
controls:0.29%
—
—
cases:13.40%
controls:0.40%
cases:28.92%
controls:2.39%
cases:29.39%
controls:6.49%
63
370
582
6079
75
152
570
6297
23
19
622
6430
—
86
26
556
6408
177
147
435
6012
139
310
334
4468
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
6.8e-01
2.2e+00
3.8e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:8.99%
controls:4.74%
cases:15.50%
controls:1.95%
cases:7.13%
controls:0.17%
—
—
cases:2.96%
controls:0.23%
cases:13.73%
controls:2.01%
cases:24.74%
controls:5.76%
58
306
587
6143
100
126
545
6323
46
11
599
6438
—
19
15
623
6419
84
124
528
6035
117
275
356
4503
Internal Medicine
11 [38004456]
7.2e-01
1.6e+00
2.3e+00
—
3.6e+00
2.8e+00
1.9e+00
cases:27.29%
controls:15.51%
cases:21.55%
controls:5.04%
cases:7.91%
controls:0.84%
—
—
cases:20.87%
controls:0.75%
cases:46.90%
controls:5.11%
cases:51.59%
controls:14.11%
176
1000
469
5449
139
325
506
6124
51
54
594
6395
—
134
48
508
6386
287
315
325
5844
244
674
229
4104
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
5.1e-01
2.3e+00
3.8e+00
—
2.8e+00
2.1e+00
1.0e+00
cases:2.64%
controls:1.60%
cases:5.12%
controls:0.53%
cases:3.88%
controls:0.09%
—
—
cases:1.71%
controls:0.11%
cases:4.90%
controls:0.62%
cases:6.77%
controls:2.53%
17
103
628
6346
33
34
612
6415
25
6
620
6443
—
11
7
631
6427
30
38
582
6121
32
121
441
4657
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.3e-01
1.6e+00
3.0e+00
2.5e+00
1.8e+00
1.5e+00
1.0e+00
cases:17.67%
controls:12.28%
cases:22.02%
controls:5.50%
cases:19.07%
controls:1.12%
cases:1.09%
controls:0.09%
cases:5.45%
controls:0.98%
cases:21.08%
controls:5.54%
cases:31.29%
controls:14.36%
114
792
531
5657
142
355
503
6094
123
72
522
6377
7
6
638
6443
35
63
607
6371
129
341
483
5818
148
686
325
4092
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
5.8e-01
1.8e+00
3.5e+00
—
3.0e+00
1.5e+00
1.2e+00
cases:3.57%
controls:2.03%
cases:4.81%
controls:0.82%
cases:2.95%
controls:0.09%
—
—
cases:1.56%
controls:0.08%
cases:3.92%
controls:0.88%
cases:7.82%
controls:2.39%
23
131
622
6318
31
53
614
6396
19
6
626
6443
—
10
5
632
6429
24
54
588
6105
37
114
436
4664
Outpatient Visit
OP [9202]
4.1e-01
7.0e-01
9.0e-01
5.3e+00
1.4e+00
1.1e+00
1.1e+00
cases:80.93%
controls:73.79%
cases:65.12%
controls:47.99%
cases:19.38%
controls:8.87%
cases:42.02%
controls:0.36%
cases:27.88%
controls:9.01%
cases:73.04%
controls:48.34%
cases:90.27%
controls:76.22%
522
4759
123
1690
420
3095
225
3354
125
572
520
5877
271
23
374
6426
179
580
463
5854
447
2977
165
3182
427
3642
46
1136
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.6e-01
1.4e+00
2.8e+00
2.2e+00
1.5e+00
1.3e+00
9.9e-01
cases:31.16%
controls:22.24%
cases:37.83%
controls:12.78%
cases:28.37%
controls:2.40%
cases:0.93%
controls:0.11%
cases:8.72%
controls:1.99%
cases:33.33%
controls:12.31%
cases:49.68%
controls:26.79%
201
1434
444
5015
244
824
401
5625
183
155
462
6294
6
7
639
6442
56
128
586
6306
204
758
408
5401
235
1280
238
3498
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
2.2e-01
1.3e+00
3.3e+00
—
2.4e+00
1.7e+00
8.9e-01
cases:6.82%
controls:5.55%
cases:7.91%
controls:2.36%
cases:9.46%
controls:0.37%
—
—
cases:1.87%
controls:0.17%
cases:9.97%
controls:1.90%
cases:13.11%
controls:5.84%
44
358
601
6091
51
152
594
6297
61
24
584
6425
—
12
11
630
6423
61
117
551
6042
62
279
411
4499
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.0e-01
2.0e+00
3.6e+00
—
1.6e+00
1.4e+00
1.0e+00
cases:11.78%
controls:8.25%
cases:17.67%
controls:2.93%
cases:13.02%
controls:0.40%
—
—
cases:1.87%
controls:0.39%
cases:12.25%
controls:3.30%
cases:21.99%
controls:9.19%
76
532
569
5917
114
189
531
6260
84
26
561
6423
—
12
25
630
6409
75
203
537
5956
104
439
369
4339
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.3e-01
1.4e+00
3.4e+00
—
1.5e+00
1.4e+00
1.0e+00
cases:13.64%
controls:9.29%
cases:16.28%
controls:4.67%
cases:14.88%
controls:0.60%
—
—
cases:3.27%
controls:0.73%
cases:14.54%
controls:4.21%
cases:26.85%
controls:11.74%
88
599
557
5850
105
301
540
6148
96
39
549
6410
—
21
47
621
6387
89
259
523
5900
127
561
346
4217
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
7.8e-01
1.4e+00
2.4e+00
—
1.8e+00
1.3e+00
1.0e+00
cases:11.32%
controls:5.54%
cases:11.78%
controls:3.21%
cases:6.67%
controls:0.62%
—
—
cases:3.12%
controls:0.51%
cases:9.64%
controls:2.86%
cases:17.76%
controls:7.12%
73
357
572
6092
76
207
569
6242
43
40
602
6409
—
20
33
622
6401
59
176
553
5983
84
340
389
4438
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.2e+00
1.9e+00
—
1.0e+50
—
3.2e+00
2.2e+00
cases:2.79%
controls:0.82%
cases:2.48%
controls:0.37%
—
—
cases:2.48%
controls:0.00%
—
—
cases:2.78%
controls:0.11%
cases:5.50%
controls:0.63%
18
53
627
6396
16
24
629
6425
—
16
0
629
6449
—
17
7
595
6152
26
30
447
4748
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.8e-02
7.0e-01
2.1e+00
2.8e+00
1.5e+00
8.5e-01
4.3e-01
cases:31.78%
controls:31.40%
cases:36.90%
controls:22.55%
cases:29.46%
controls:4.87%
cases:2.48%
controls:0.16%
cases:15.58%
controls:3.95%
cases:41.18%
controls:22.99%
cases:50.53%
controls:39.97%
205
2025
440
4424
238
1454
407
4995
190
314
455
6135
16
10
629
6439
100
254
542
6180
252
1416
360
4743
239
1910
234
2868
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
7.7e-01
2.0e+00
3.7e+00
—
—
1.5e+00
1.2e+00
cases:3.10%
controls:1.46%
cases:5.27%
controls:0.74%
cases:3.10%
controls:0.08%
—
—
—
—
cases:2.12%
controls:0.49%
cases:4.86%
controls:1.59%
20
94
625
6355
34
48
611
6401
20
5
625
6444
—
—
13
30
599
6129
23
76
450
4702
INR in Blood by Coagulation assay
34714-6 [3032080]
3.7e-01
1.1e+00
2.1e+00
2.0e+00
9.7e-01
1.1e+00
9.5e-01
cases:14.11%
controls:10.23%
cases:12.87%
controls:4.59%
cases:10.39%
controls:1.33%
cases:0.93%
controls:0.12%
cases:3.74%
controls:1.45%
cases:14.22%
controls:5.07%
cases:26.00%
controls:11.93%
91
660
554
5789
83
296
562
6153
67
86
578
6363
6
8
639
6441
24
93
618
6341
87
312
525
5847
123
570
350
4208
MCH [Entitic mass]
28539-5 [3035941]
1.1e-01
9.0e-01
2.2e+00
2.6e+00
1.5e+00
9.6e-01
3.2e-01
cases:53.18%
controls:50.33%
cases:59.84%
controls:37.62%
cases:43.41%
controls:7.82%
cases:3.26%
controls:0.25%
cases:23.68%
controls:6.51%
cases:61.27%
controls:37.64%
cases:67.23%
controls:59.90%
343
3246
302
3203
386
2426
259
4023
280
504
365
5945
21
16
624
6433
152
419
490
6015
375
2318
237
3841
318
2862
155
1916
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
9.0e-01
2.2e+00
2.6e+00
1.5e+00
9.6e-01
3.2e-01
cases:53.33%
controls:50.40%
cases:59.84%
controls:37.73%
cases:43.41%
controls:7.85%
cases:3.26%
controls:0.25%
cases:23.52%
controls:6.51%
cases:61.27%
controls:37.67%
cases:67.23%
controls:59.94%
344
3250
301
3199
386
2433
259
4016
280
506
365
5943
21
16
624
6433
151
419
491
6015
375
2320
237
3839
318
2864
155
1914
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.1e-01
9.0e-01
2.2e+00
2.6e+00
1.5e+00
9.6e-01
3.1e-01
cases:53.33%
controls:50.47%
cases:59.84%
controls:37.73%
cases:43.26%
controls:7.82%
cases:3.26%
controls:0.25%
cases:23.68%
controls:6.54%
cases:61.27%
controls:37.77%
cases:67.23%
controls:60.03%
344
3255
301
3194
386
2433
259
4016
279
504
366
5945
21
16
624
6433
152
421
490
6013
375
2326
237
3833
318
2868
155
1910
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
9.0e-01
2.2e+00
2.5e+00
1.5e+00
9.7e-01
3.1e-01
cases:53.33%
controls:50.40%
cases:59.84%
controls:37.70%
cases:43.41%
controls:7.82%
cases:3.26%
controls:0.26%
cases:23.68%
controls:6.53%
cases:61.27%
controls:37.59%
cases:67.23%
controls:59.98%
344
3250
301
3199
386
2431
259
4018
280
504
365
5945
21
17
624
6432
152
420
490
6014
375
2315
237
3844
318
2866
155
1912
Platelets [#/volume] in Blood
26515-7 [3007461]
1.2e-01
9.0e-01
2.2e+00
2.5e+00
1.5e+00
9.7e-01
3.2e-01
cases:53.18%
controls:50.09%
cases:59.69%
controls:37.56%
cases:43.41%
controls:7.83%
cases:3.26%
controls:0.26%
cases:23.68%
controls:6.53%
cases:61.27%
controls:37.60%
cases:67.23%
controls:59.90%
343
3230
302
3219
385
2422
260
4027
280
505
365
5944
21
17
624
6432
152
420
490
6014
375
2316
237
3843
318
2862
155
1916
CBC panel - Blood by Automated count
58410-2 [40761511]
1.5e-01
8.8e-01
1.9e+00
2.4e+00
1.5e+00
9.8e-01
4.9e-01
cases:45.89%
controls:42.12%
cases:44.03%
controls:24.61%
cases:21.55%
controls:4.14%
cases:1.71%
controls:0.16%
cases:13.40%
controls:3.39%
cases:45.75%
controls:24.01%
cases:59.20%
controls:47.07%
296
2716
349
3733
284
1587
361
4862
139
267
506
6182
11
10
634
6439
86
218
556
6216
280
1479
332
4680
280
2249
193
2529
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
9.0e-01
2.2e+00
2.5e+00
1.5e+00
9.6e-01
3.1e-01
cases:53.33%
controls:50.41%
cases:59.84%
controls:37.71%
cases:43.41%
controls:7.85%
cases:3.26%
controls:0.26%
cases:23.68%
controls:6.53%
cases:61.27%
controls:37.70%
cases:67.23%
controls:60.03%
344
3251
301
3198
386
2432
259
4017
280
506
365
5943
21
17
624
6432
152
420
490
6014
375
2322
237
3837
318
2868
155
1910
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.1e-01
9.0e-01
2.2e+00
2.5e+00
1.5e+00
9.6e-01
3.1e-01
cases:53.33%
controls:50.49%
cases:59.84%
controls:37.77%
cases:43.41%
controls:7.86%
cases:3.26%
controls:0.26%
cases:23.68%
controls:6.53%
cases:61.27%
controls:37.70%
cases:67.23%
controls:60.07%
344
3256
301
3193
386
2436
259
4013
280
507
365
5942
21
17
624
6432
152
420
490
6014
375
2322
237
3837
318
2870
155
1908
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.6e-01
1.4e+00
3.4e+00
—
—
1.1e+00
1.3e+00
cases:4.81%
controls:2.31%
cases:3.72%
controls:0.96%
cases:2.33%
controls:0.08%
—
—
—
—
cases:2.45%
controls:0.81%
cases:6.13%
controls:1.78%
31
149
614
6300
24
62
621
6387
15
5
630
6444
—
—
15
50
597
6109
29
85
444
4693
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.3e-01
1.3e+00
2.6e+00
—
1.4e+00
1.2e+00
9.6e-01
cases:13.64%
controls:8.53%
cases:16.28%
controls:5.23%
cases:11.32%
controls:0.93%
—
—
cases:3.27%
controls:0.84%
cases:13.24%
controls:4.59%
cases:20.30%
controls:8.85%
88
550
557
5899
105
337
540
6112
73
60
572
6389
—
21
54
621
6380
81
283
531
5876
96
423
377
4355
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.1e+00
2.3e+00
3.8e+00
—
—
1.8e+00
7.2e-01
cases:1.40%
controls:0.47%
cases:3.88%
controls:0.42%
cases:4.03%
controls:0.09%
—
—
—
—
cases:1.63%
controls:0.28%
cases:3.81%
controls:1.88%
9
30
636
6419
25
27
620
6422
26
6
619
6443
—
—
10
17
602
6142
18
90
455
4688
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.8e-01
1.0e+00
2.2e+00
2.2e+00
1.1e+00
8.0e-01
4.2e-01
cases:47.29%
controls:42.78%
cases:53.02%
controls:28.45%
cases:33.80%
controls:5.24%
cases:1.40%
controls:0.16%
cases:11.84%
controls:4.23%
cases:47.55%
controls:29.03%
cases:64.06%
controls:53.85%
305
2759
340
3690
342
1835
303
4614
218
338
427
6111
9
10
636
6439
76
272
566
6162
291
1788
321
4371
303
2573
170
2205
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
1.3e+00
1.3e+00
1.4e+00
—
1.8e+00
1.7e+00
1.7e+00
cases:2.95%
controls:0.84%
cases:2.64%
controls:0.70%
cases:1.24%
controls:0.29%
—
—
cases:1.25%
controls:0.22%
cases:3.27%
controls:0.60%
cases:4.86%
controls:0.94%
19
54
626
6395
17
45
628
6404
8
19
637
6430
—
8
14
634
6420
20
37
592
6122
23
45
450
4733
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
8.8e-01
1.9e+00
3.6e+00
—
—
1.3e+00
6.8e-01
cases:7.13%
controls:3.10%
cases:6.36%
controls:1.02%
cases:3.41%
controls:0.09%
—
—
—
—
cases:2.61%
controls:0.70%
cases:5.92%
controls:3.10%
46
200
599
6249
41
66
604
6383
22
6
623
6443
—
—
16
43
596
6116
28
148
445
4630
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
7.2e-01
1.7e+00
2.9e+00
—
—
1.6e+00
8.1e-01
cases:4.50%
controls:2.23%
cases:4.34%
controls:0.85%
cases:2.48%
controls:0.14%
—
—
—
—
cases:4.74%
controls:0.97%
cases:6.98%
controls:3.22%
29
144
616
6305
28
55
617
6394
16
9
629
6440
—
—
29
60
583
6099
33
154
440
4624
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
2.1e+00
3.5e+00
—
1.0e+50
—
—
2.0e+00
cases:2.33%
controls:0.28%
cases:3.10%
controls:0.09%
—
—
cases:3.41%
controls:0.00%
—
—
—
—
cases:3.17%
controls:0.44%
15
18
630
6431
20
6
625
6443
—
22
0
623
6449
—
—
15
21
458
4757
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
8.5e-01
1.5e+00
3.1e+00
—
—
1.3e+00
7.7e-01
cases:7.75%
controls:3.47%
cases:4.81%
controls:1.07%
cases:1.71%
controls:0.08%
—
—
—
—
cases:2.12%
controls:0.60%
cases:5.07%
controls:2.41%
50
224
595
6225
31
69
614
6380
11
5
634
6444
—
—
13
37
599
6122
24
115
449
4663
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
6.6e-01
1.6e+00
2.1e+00
—
2.1e+00
9.9e-01
6.8e-01
cases:4.96%
controls:2.64%
cases:8.06%
controls:1.78%
cases:1.71%
controls:0.20%
—
—
cases:1.40%
controls:0.17%
cases:5.07%
controls:1.95%
cases:13.74%
controls:7.47%
32
170
613
6279
52
115
593
6334
11
13
634
6436
—
9
11
633
6423
31
120
581
6039
65
357
408
4421
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.8e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.0e-01
cases:19.07%
controls:12.72%
cases:20.00%
controls:7.41%
cases:13.64%
controls:1.40%
—
—
cases:4.98%
controls:1.18%
cases:17.48%
controls:6.72%
cases:28.12%
controls:13.73%
123
820
522
5629
129
478
516
5971
88
90
557
6359
—
32
76
610
6358
107
414
505
5745
133
656
340
4122
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.8e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.1e-01
cases:19.07%
controls:12.68%
cases:19.84%
controls:7.43%
cases:13.80%
controls:1.43%
—
—
cases:4.98%
controls:1.21%
cases:17.81%
controls:6.82%
cases:28.12%
controls:13.62%
123
818
522
5631
128
479
517
5970
89
92
556
6357
—
32
78
610
6356
109
420
503
5739
133
651
340
4127
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.8e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.0e-01
cases:19.07%
controls:12.70%
cases:20.00%
controls:7.41%
cases:13.64%
controls:1.41%
—
—
cases:4.98%
controls:1.21%
cases:17.65%
controls:6.80%
cases:28.12%
controls:13.67%
123
819
522
5630
129
478
516
5971
88
91
557
6358
—
32
78
610
6356
108
419
504
5740
133
653
340
4125
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.1e-01
9.6e-01
1.9e+00
2.4e+00
9.8e-01
7.3e-01
4.3e-01
cases:42.17%
controls:37.22%
cases:40.31%
controls:20.50%
cases:21.55%
controls:3.77%
cases:2.02%
controls:0.19%
cases:8.26%
controls:3.26%
cases:34.97%
controls:20.64%
cases:53.28%
controls:42.53%
272
2400
373
4049
260
1322
385
5127
139
243
506
6206
13
12
632
6437
53
210
589
6224
214
1271
398
4888
252
2032
221
2746
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.0e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.4e-01
cases:18.76%
controls:13.40%
cases:20.16%
controls:8.08%
cases:14.88%
controls:1.55%
—
—
cases:5.61%
controls:1.31%
cases:20.26%
controls:7.55%
cases:31.92%
controls:15.45%
121
864
524
5585
130
521
515
5928
96
100
549
6349
—
36
84
606
6350
124
465
488
5694
151
738
322
4040
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.4e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.2e-01
cases:19.84%
controls:13.72%
cases:21.24%
controls:8.28%
cases:14.88%
controls:1.58%
—
—
cases:5.61%
controls:1.37%
cases:20.59%
controls:7.68%
cases:32.35%
controls:15.97%
128
885
517
5564
137
534
508
5915
96
102
549
6347
—
36
88
606
6346
126
473
486
5686
153
763
320
4015
Basophils [#/volume] in Blood
26444-0 [3006315]
3.9e-01
1.1e+00
2.4e+00
—
1.5e+00
1.1e+00
9.4e-01
cases:18.60%
controls:13.46%
cases:20.47%
controls:8.14%
cases:14.88%
controls:1.57%
—
—
cases:5.61%
controls:1.32%
cases:20.26%
controls:7.53%
cases:31.92%
controls:15.51%
120
868
525
5581
132
525
513
5924
96
101
549
6348
—
36
85
606
6349
124
464
488
5695
151
741
322
4037
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
5.4e-01
1.7e+00
3.5e+00
—
2.1e+00
1.0e+00
6.6e-01
cases:8.37%
controls:5.04%
cases:8.06%
controls:1.55%
cases:2.95%
controls:0.09%
—
—
cases:0.78%
controls:0.09%
cases:4.08%
controls:1.53%
cases:9.51%
controls:5.17%
54
325
591
6124
52
100
593
6349
19
6
626
6443
—
5
6
637
6428
25
94
587
6065
45
247
428
4531
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
1.5e+00
3.2e+00
1.0e+50
—
—
2.6e+00
1.3e+00
cases:2.17%
controls:0.48%
cases:4.19%
controls:0.17%
cases:2.17%
controls:0.00%
—
—
—
—
cases:1.31%
controls:0.10%
cases:2.33%
controls:0.67%
14
31
631
6418
27
11
618
6438
14
0
631
6449
—
—
8
6
604
6153
11
32
462
4746
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.6e-01
1.1e+00
2.4e+00
—
1.4e+00
1.1e+00
9.1e-01
cases:19.07%
controls:12.96%
cases:20.31%
controls:7.55%
cases:13.49%
controls:1.41%
—
—
cases:4.83%
controls:1.23%
cases:17.81%
controls:6.95%
cases:29.18%
controls:14.23%
123
836
522
5613
131
487
514
5962
87
91
558
6358
—
31
79
611
6355
109
428
503
5731
138
680
335
4098
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.6e-01
1.0e+00
2.4e+00
—
1.4e+00
1.1e+00
9.3e-01
cases:18.60%
controls:12.65%
cases:18.45%
controls:7.41%
cases:13.33%
controls:1.40%
—
—
cases:4.83%
controls:1.18%
cases:17.81%
controls:6.88%
cases:28.75%
controls:13.79%
120
816
525
5633
119
478
526
5971
86
90
559
6359
—
31
76
611
6358
109
424
503
5735
136
659
337
4119
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.3e-01
1.1e+00
2.4e+00
—
1.4e+00
1.1e+00
9.1e-01
cases:20.00%
controls:13.99%
cases:20.93%
controls:8.42%
cases:15.04%
controls:1.64%
—
—
cases:5.61%
controls:1.41%
cases:20.59%
controls:7.76%
cases:32.14%
controls:15.97%
129
902
516
5547
135
543
510
5906
97
106
548
6343
—
36
91
606
6343
126
478
486
5681
152
763
321
4015
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
1.5e+00
3.3e+00
1.0e+50
—
—
2.5e+00
1.2e+00
cases:2.02%
controls:0.45%
cases:4.03%
controls:0.16%
cases:1.86%
controls:0.00%
—
—
—
—
cases:1.14%
controls:0.10%
cases:2.11%
controls:0.63%
13
29
632
6420
26
10
619
6439
12
0
633
6449
—
—
7
6
605
6153
10
30
463
4748
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.3e-01
1.4e+00
2.4e+00
—
1.4e+00
1.1e+00
6.1e-01
cases:28.99%
controls:20.92%
cases:27.91%
controls:8.70%
cases:11.47%
controls:1.18%
—
—
cases:3.89%
controls:1.03%
cases:21.24%
controls:8.31%
cases:36.79%
controls:24.11%
187
1349
458
5100
180
561
465
5888
74
76
571
6373
—
25
66
617
6368
130
512
482
5647
174
1152
299
3626
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
4.3e-01
1.0e+00
2.2e+00
—
2.2e+00
1.2e+00
6.4e-01
cases:6.82%
controls:4.56%
cases:6.20%
controls:2.36%
cases:2.95%
controls:0.34%
—
—
cases:2.49%
controls:0.30%
cases:7.52%
controls:2.34%
cases:14.16%
controls:8.02%
44
294
601
6155
40
152
605
6297
19
22
626
6427
—
16
19
626
6415
46
144
566
6015
67
383
406
4395
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.3e-01
1.8e+00
3.2e+00
—
—
1.1e+00
9.6e-01
cases:3.88%
controls:2.09%
cases:4.50%
controls:0.78%
cases:2.17%
controls:0.09%
—
—
—
—
cases:2.29%
controls:0.75%
cases:6.13%
controls:2.45%
25
135
620
6314
29
50
616
6399
14
6
631
6443
—
—
14
46
598
6113
29
117
444
4661
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
5.2e-01
1.2e+00
2.1e+00
—
1.8e+00
9.8e-01
9.8e-01
cases:2.48%
controls:1.49%
cases:3.41%
controls:1.10%
cases:1.86%
controls:0.23%
—
—
cases:1.25%
controls:0.20%
cases:2.94%
controls:1.12%
cases:6.34%
controls:2.47%
16
96
629
6353
22
71
623
6378
12
15
633
6434
—
8
13
634
6421
18
69
594
6090
30
118
443
4660
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.3e-01
9.5e-01
2.4e+00
—
1.6e+00
1.1e+00
9.3e-01
cases:15.35%
controls:11.58%
cases:19.69%
controls:8.64%
cases:17.21%
controls:1.91%
—
—
cases:7.94%
controls:1.63%
cases:23.53%
controls:9.22%
cases:32.35%
controls:15.89%
99
747
546
5702
127
557
518
5892
111
123
534
6326
—
51
105
591
6329
144
568
468
5591
153
759
320
4019
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.9e-01
6.2e-01
1.8e+00
2.6e+00
9.3e-01
6.3e-01
3.6e-01
cases:36.59%
controls:32.28%
cases:36.28%
controls:23.43%
cases:21.71%
controls:4.53%
cases:1.86%
controls:0.14%
cases:8.88%
controls:3.70%
cases:36.60%
controls:23.48%
cases:52.64%
controls:43.60%
236
2082
409
4367
234
1511
411
4938
140
292
505
6157
12
9
633
6440
57
238
585
6196
224
1446
388
4713
249
2083
224
2695
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
8.0e-01
2.4e+00
—
—
—
2.4e+00
2.1e+00
cases:3.41%
controls:1.57%
cases:6.51%
controls:0.64%
—
—
—
—
—
—
cases:5.88%
controls:0.55%
cases:12.05%
controls:1.67%
22
101
623
6348
42
41
603
6408
—
—
—
36
34
576
6125
57
80
416
4698
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
6.4e-01
1.0e+00
2.1e+00
—
1.7e+00
9.7e-01
1.0e+00
cases:2.95%
controls:1.58%
cases:3.26%
controls:1.18%
cases:2.02%
controls:0.25%
—
—
cases:1.25%
controls:0.23%
cases:2.94%
controls:1.14%
cases:6.77%
controls:2.53%
19
102
626
6347
21
76
624
6373
13
16
632
6433
—
8
15
634
6419
18
70
594
6089
32
121
441
4657
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
6.1e-01
1.1e+00
2.0e+00
—
1.7e+00
9.8e-01
1.0e+00
cases:2.79%
controls:1.54%
cases:3.26%
controls:1.15%
cases:1.86%
controls:0.25%
—
—
cases:1.25%
controls:0.23%
cases:2.94%
controls:1.12%
cases:6.34%
controls:2.39%
18
99
627
6350
21
74
624
6375
12
16
633
6433
—
8
15
634
6419
18
69
594
6090
30
114
443
4664
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
3.6e-01
1.3e+00
2.5e+00
—
1.6e+00
9.4e-01
4.7e-01
cases:11.01%
controls:7.91%
cases:12.09%
controls:3.77%
cases:3.41%
controls:0.29%
—
—
cases:1.71%
controls:0.34%
cases:8.66%
controls:3.56%
cases:19.87%
controls:13.39%
71
510
574
5939
78
243
567
6206
22
19
623
6430
—
11
22
631
6412
53
219
559
5940
94
640
379
4138
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
5.3e-01
1.9e+00
3.9e+00
—
—
7.3e-01
8.9e-01
cases:6.98%
controls:4.23%
cases:8.22%
controls:1.35%
cases:3.72%
controls:0.08%
—
—
—
—
cases:2.29%
controls:1.12%
cases:10.36%
controls:4.52%
45
273
600
6176
53
87
592
6362
24
5
621
6444
—
—
14
69
598
6090
49
216
424
4562
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.5e-01
1.3e+00
2.2e+00
—
1.3e+00
7.7e-01
5.7e-01
cases:31.32%
controls:22.59%
cases:30.08%
controls:10.23%
cases:13.18%
controls:1.60%
—
—
cases:4.52%
controls:1.27%
cases:17.97%
controls:9.22%
cases:36.79%
controls:24.80%
202
1457
443
4992
194
660
451
5789
85
103
560
6346
—
29
82
613
6352
110
568
502
5591
174
1185
299
3593
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.5e-01
7.1e-01
1.6e+00
2.5e+00
8.6e-01
5.3e-01
3.7e-01
cases:43.10%
controls:39.56%
cases:42.17%
controls:26.36%
cases:19.53%
controls:4.61%
cases:2.33%
controls:0.19%
cases:8.41%
controls:3.73%
cases:38.07%
controls:26.53%
cases:58.99%
controls:49.96%
278
2551
367
3898
272
1700
373
4749
126
297
519
6152
15
12
630
6437
54
240
588
6194
233
1634
379
4525
279
2387
194
2391
Laboratory Visit
OMOP4822461 [32036]
1.2e-01
6.2e-01
1.8e+00
2.3e+00
1.2e+00
6.6e-01
1.7e-01
cases:59.38%
controls:56.38%
cases:63.41%
controls:48.15%
cases:49.61%
controls:13.61%
cases:6.05%
controls:0.67%
cases:32.87%
controls:12.76%
cases:65.03%
controls:48.89%
cases:68.50%
controls:64.82%
383
3636
262
2813
409
3105
236
3344
320
878
325
5571
39
43
606
6406
211
821
431
5613
398
3011
214
3148
324
3097
149
1681
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.9e-01
8.3e-01
1.9e+00
—
2.0e+00
9.8e-01
7.3e-01
cases:8.53%
controls:6.50%
cases:5.58%
controls:2.51%
cases:1.71%
controls:0.25%
—
—
cases:1.71%
controls:0.23%
cases:5.39%
controls:2.09%
cases:13.11%
controls:6.76%
55
419
590
6030
36
162
609
6287
11
16
634
6433
—
11
15
631
6419
33
129
579
6030
62
323
411
4455
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.5e-01
7.3e-01
1.6e+00
2.4e+00
8.4e-01
5.4e-01
3.5e-01
cases:43.72%
controls:39.98%
cases:42.95%
controls:26.67%
cases:19.69%
controls:4.70%
cases:2.17%
controls:0.20%
cases:8.41%
controls:3.81%
cases:38.73%
controls:26.84%
cases:58.99%
controls:50.40%
282
2578
363
3871
277
1720
368
4729
127
303
518
6146
14
13
631
6436
54
245
588
6189
237
1653
375
4506
279
2408
194
2370
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.3e-01
7.0e-01
1.8e+00
2.4e+00
9.5e-01
5.7e-01
3.2e-01
cases:48.06%
controls:44.84%
cases:48.84%
controls:32.21%
cases:28.53%
controls:6.14%
cases:2.33%
controls:0.22%
cases:12.15%
controls:5.07%
cases:46.08%
controls:32.51%
cases:63.42%
controls:55.86%
310
2892
335
3557
315
2077
330
4372
184
396
461
6053
15
14
630
6435
78
326
564
6108
282
2002
330
4157
300
2669
173
2109
Blasts/Leukocytes in Blood
26446-5 [3025159]
5.0e-01
1.1e+00
2.1e+00
—
1.8e+00
8.9e-01
1.1e+00
cases:2.48%
controls:1.52%
cases:3.26%
controls:1.12%
cases:2.02%
controls:0.25%
—
—
cases:1.40%
controls:0.23%
cases:2.94%
controls:1.23%
cases:7.19%
controls:2.41%
16
98
629
6351
21
72
624
6377
13
16
632
6433
—
9
15
633
6419
18
76
594
6083
34
115
439
4663
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
4.7e-01
1.0e+00
2.2e+00
—
2.0e+00
8.8e-01
2.2e-01
cases:6.98%
controls:4.47%
cases:3.88%
controls:1.40%
cases:0.93%
controls:0.11%
—
—
cases:0.93%
controls:0.12%
cases:3.59%
controls:1.53%
cases:5.71%
controls:4.65%
45
288
600
6161
25
90
620
6359
6
7
639
6442
—
6
8
636
6426
22
94
590
6065
27
222
446
4556
Case Management Agency
251B00000X [38004193]
1.7e-01
2.9e-01
5.2e-01
4.2e+00
8.4e-01
4.2e-01
1.8e-01
cases:74.11%
controls:70.82%
cases:69.46%
controls:63.10%
cases:37.05%
controls:25.99%
cases:48.37%
controls:1.33%
cases:45.48%
controls:26.53%
cases:74.51%
controls:65.77%
cases:83.30%
controls:80.58%
478
4567
167
1882
448
4069
197
2380
239
1676
406
4773
312
86
333
6363
292
1707
350
4727
456
4051
156
2108
394
3850
79
928
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.0e-01
8.8e-01
2.0e+00
—
1.1e+00
1.0e+00
8.4e-01
cases:20.16%
controls:15.77%
cases:20.16%
controls:9.44%
cases:14.88%
controls:2.23%
—
—
cases:6.07%
controls:2.04%
cases:20.92%
controls:8.56%
cases:32.98%
controls:17.54%
130
1017
515
5432
130
609
515
5840
96
144
549
6305
—
39
131
603
6303
128
527
484
5632
156
838
317
3940
androstanolone
A14AA01 [21600917]
1.2e+00
1.3e+00
1.7e+00
—
2.1e+00
1.8e+00
1.9e+00
cases:1.71%
controls:0.53%
cases:1.55%
controls:0.42%
cases:0.93%
controls:0.17%
—
—
cases:1.25%
controls:0.16%
cases:2.12%
controls:0.36%
cases:3.81%
controls:0.59%
11
34
634
6415
10
27
635
6422
6
11
639
6438
—
8
10
634
6424
13
22
599
6137
18
28
455
4750
Other specified special examinations
Z01.8 [45581003]
6.1e-01
1.4e+00
2.9e+00
—
—
1.5e+00
7.0e-01
cases:5.27%
controls:2.95%
cases:3.26%
controls:0.82%
cases:1.40%
controls:0.08%
—
—
—
—
cases:2.94%
controls:0.68%
cases:5.71%
controls:2.91%
34
190
611
6259
21
53
624
6396
9
5
636
6444
—
—
18
42
594
6117
27
139
446
4639
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
2.0e-01
1.6e+00
2.9e+00
—
—
1.1e+00
6.1e-01
cases:6.36%
controls:5.29%
cases:7.13%
controls:1.46%
cases:2.02%
controls:0.11%
—
—
—
—
cases:2.94%
controls:0.99%
cases:5.07%
controls:2.83%
41
341
604
6108
46
94
599
6355
13
7
632
6442
—
—
18
61
594
6098
24
135
449
4643
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
5.2e-01
2.1e+00
—
—
—
2.2e+00
1.2e+00
cases:2.48%
controls:1.49%
cases:4.96%
controls:0.62%
—
—
—
—
—
—
cases:4.25%
controls:0.47%
cases:6.13%
controls:1.86%
16
96
629
6353
32
40
613
6409
—
—
—
26
29
586
6130
29
89
444
4689
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
4.8e-01
2.3e+00
—
—
—
2.1e+00
1.1e+00
cases:1.86%
controls:1.16%
cases:4.19%
controls:0.42%
—
—
—
—
—
—
cases:4.08%
controls:0.50%
cases:5.50%
controls:1.90%
12
75
633
6374
27
27
618
6422
—
—
—
25
31
587
6128
26
91
447
4687
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-2.0e-01
2.9e-01
1.6e+00
2.4e+00
1.2e+00
3.6e-01
-1.1e-01
cases:32.40%
controls:36.92%
cases:30.70%
controls:24.84%
cases:20.00%
controls:4.93%
cases:2.02%
controls:0.19%
cases:12.62%
controls:4.09%
cases:31.54%
controls:24.35%
cases:40.17%
controls:42.86%
209
2381
436
4068
198
1602
447
4847
129
318
516
6131
13
12
632
6437
81
263
561
6171
193
1500
419
4659
190
2048
283
2730
Pulmonary Disease
29 [38004472]
5.2e-01
8.9e-01
1.5e+00
—
1.3e+00
7.4e-01
5.8e-01
cases:15.35%
controls:9.74%
cases:10.85%
controls:4.74%
cases:2.95%
controls:0.68%
—
—
cases:2.34%
controls:0.67%
cases:9.80%
controls:4.94%
cases:17.76%
controls:10.82%
99
628
546
5821
70
306
575
6143
19
44
626
6405
—
15
43
627
6391
60
304
552
5855
84
517
389
4261
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.1e-01
1.1e+00
2.0e+00
—
8.7e-01
6.0e-01
5.3e-01
cases:33.64%
controls:25.14%
cases:28.99%
controls:11.75%
cases:8.99%
controls:1.38%
—
—
cases:3.58%
controls:1.54%
cases:19.77%
controls:11.95%
cases:41.23%
controls:29.30%
217
1621
428
4828
187
758
458
5691
58
89
587
6360
—
23
99
619
6335
121
736
491
5423
195
1400
278
3378
Sleep apnoea
G47.3 [45562094]
6.0e-01
7.9e-01
1.3e+00
—
1.5e+00
7.5e-01
5.2e-01
cases:9.77%
controls:5.63%
cases:7.91%
controls:3.75%
cases:2.48%
controls:0.71%
—
—
cases:2.34%
controls:0.53%
cases:7.84%
controls:3.85%
cases:12.68%
controls:7.97%
63
363
582
6086
51
242
594
6207
16
46
629
6403
—
15
34
627
6400
48
237
564
5922
60
381
413
4397
Outpatient Hospital
22 [8756]
2.0e-01
6.7e-01
1.5e+00
—
1.7e+00
9.9e-01
5.4e-01
cases:22.33%
controls:19.07%
cases:8.06%
controls:4.31%
cases:2.79%
controls:0.65%
—
—
cases:2.34%
controls:0.45%
cases:9.48%
controls:3.73%
cases:18.39%
controls:11.64%
144
1230
501
5219
52
278
593
6171
18
42
627
6407
—
15
29
627
6405
58
230
554
5929
87
556
386
4222
Office Visit
OMOP4822458 [581477]
4.9e-01
7.2e-01
8.7e-01
—
2.6e+00
1.5e+00
8.2e-01
cases:10.39%
controls:6.65%
cases:3.10%
controls:1.54%
cases:0.78%
controls:0.33%
—
—
cases:1.40%
controls:0.11%
cases:4.90%
controls:1.19%
cases:8.67%
controls:4.02%
67
429
578
6020
20
99
625
6350
5
21
640
6428
—
9
7
633
6427
30
73
582
6086
41
192
432
4586
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
1.2e+00
3.5e+00
1.0e+50
—
—
—
1.8e+00
cases:1.09%
controls:0.33%
cases:3.10%
controls:0.09%
cases:1.24%
controls:0.00%
—
—
—
—
—
—
cases:1.48%
controls:0.25%
7
21
638
6428
20
6
625
6443
8
0
637
6449
—
—
—
7
12
466
4766
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
5.0e-01
1.1e+00
2.2e+00
—
8.9e-01
8.2e-01
6.8e-01
cases:14.42%
controls:9.26%
cases:13.18%
controls:4.73%
cases:4.19%
controls:0.48%
—
—
cases:1.25%
controls:0.51%
cases:9.64%
controls:4.50%
cases:23.89%
controls:13.75%
93
597
552
5852
85
305
560
6144
27
31
618
6418
—
8
33
634
6401
59
277
553
5882
113
657
360
4121
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
1.6e+00
1.9e+00
—
—
—
2.6e+00
2.7e+00
cases:0.93%
controls:0.19%
cases:0.93%
controls:0.14%
—
—
—
—
—
—
cases:1.31%
controls:0.10%
cases:3.59%
controls:0.25%
6
12
639
6437
6
9
639
6440
—
—
—
8
6
604
6153
17
12
456
4766
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3.0e-01
1.1e+00
2.0e+00
—
8.6e-01
5.9e-01
4.2e-01
cases:39.84%
controls:32.92%
cases:38.14%
controls:17.07%
cases:14.11%
controls:2.16%
—
—
cases:4.67%
controls:2.04%
cases:26.96%
controls:17.05%
cases:49.68%
controls:39.26%
257
2123
388
4326
246
1101
399
5348
91
139
554
6310
—
30
131
612
6303
165
1050
447
5109
235
1876
238
2902
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-3.6e-02
6.4e-01
2.6e+00
—
—
1.4e+00
1.2e+00
cases:2.17%
controls:2.25%
cases:1.55%
controls:0.82%
cases:1.24%
controls:0.09%
—
—
—
—
cases:2.29%
controls:0.55%
cases:8.03%
controls:2.55%
14
145
631
6304
10
53
635
6396
8
6
637
6443
—
—
14
34
598
6125
38
122
435
4656
Malaise and fatigue
R53 [45553741]
7.2e-01
1.4e+00
—
—
2.1e+00
8.9e-01
5.8e-01
cases:5.74%
controls:2.88%
cases:5.12%
controls:1.33%
—
—
—
—
cases:1.25%
controls:0.16%
cases:3.59%
controls:1.51%
cases:7.40%
controls:4.29%
37
186
608
6263
33
86
612
6363
—
—
8
10
634
6424
22
93
590
6066
35
205
438
4573
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
2.2e+00
—
—
1.0e+50
—
—
2.9e+00
cases:0.93%
controls:0.11%
—
—
—
—
cases:0.93%
controls:0.00%
—
—
—
—
cases:1.90%
controls:0.10%
6
7
639
6442
—
—
6
0
639
6449
—
—
9
5
464
4773
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
3.8e-01
1.3e+00
2.1e+00
—
1.6e+00
5.7e-01
5.0e-01
cases:9.61%
controls:6.78%
cases:8.84%
controls:2.53%
cases:2.64%
controls:0.34%
—
—
cases:1.25%
controls:0.25%
cases:4.58%
controls:2.63%
cases:12.05%
controls:7.68%
62
437
583
6012
57
163
588
6286
17
22
628
6427
—
8
16
634
6418
28
162
584
5997
57
367
416
4411
pH of Serum or Plasma
2753-2 [3018418]
1.7e-01
9.4e-01
2.5e+00
—
1.1e+00
7.2e-01
8.8e-01
cases:6.20%
controls:5.29%
cases:7.29%
controls:2.98%
cases:4.19%
controls:0.37%
—
—
cases:1.09%
controls:0.36%
cases:4.74%
controls:2.35%
cases:16.28%
controls:7.45%
40
341
605
6108
47
192
598
6257
27
24
618
6425
—
7
23
635
6411
29
145
583
6014
77
356
396
4422
Supplier / Service Provider
OMOP5117446 [33004]
-4.9e-01
-5.9e-01
8.6e-01
—
1.0e+50
2.9e+00
2.6e+00
cases:21.55%
controls:30.90%
cases:5.27%
controls:9.13%
cases:1.71%
controls:0.73%
—
—
cases:1.09%
controls:0.00%
cases:9.64%
controls:0.58%
cases:16.91%
controls:1.53%
139
1993
506
4456
34
589
611
5860
11
47
634
6402
—
7
0
635
6434
59
36
553
6123
80
73
393
4705
12 lead EKG panel
34534-8 [3044889]
2.6e-01
7.2e-01
1.8e+00
—
1.4e+00
6.7e-01
3.5e-01
cases:25.58%
controls:20.92%
cases:17.83%
controls:9.54%
cases:6.82%
controls:1.16%
—
—
cases:3.89%
controls:1.01%
cases:16.67%
controls:9.30%
cases:32.56%
controls:25.35%
165
1349
480
5100
115
615
530
5834
44
75
601
6374
—
25
65
617
6369
102
573
510
5586
154
1211
319
3567
EKG study
11524-6 [3013512]
5.7e-01
7.0e-01
2.0e+00
—
1.1e+00
7.2e-01
6.6e-01
cases:13.33%
controls:8.03%
cases:7.29%
controls:3.75%
cases:2.64%
controls:0.36%
—
—
cases:1.25%
controls:0.44%
cases:8.01%
controls:4.08%
cases:18.60%
controls:10.57%
86
518
559
5931
47
242
598
6207
17
23
628
6426
—
8
28
634
6406
49
251
563
5908
88
505
385
4273
Foot and toes X-ray examination
NH3AA [2001308267]
2.4e-01
1.8e+00
—
—
—
1.8e+00
1.1e+00
cases:1.40%
controls:1.10%
cases:1.55%
controls:0.26%
—
—
—
—
—
—
cases:1.14%
controls:0.19%
cases:2.96%
controls:1.03%
9
71
636
6378
10
17
635
6432
—
—
—
7
12
605
6147
14
49
459
4729
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
6.4e-01
2.5e+00
—
—
—
2.1e+00
1.2e+00
cases:1.09%
controls:0.57%
cases:2.48%
controls:0.20%
—
—
—
—
—
—
cases:1.80%
controls:0.23%
cases:1.90%
controls:0.61%
7
37
638
6412
16
13
629
6436
—
—
—
11
14
601
6145
9
29
464
4749
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.8e-01
1.2e+00
—
—
—
1.5e+00
9.7e-01
cases:8.06%
controls:3.50%
cases:2.95%
controls:0.91%
—
—
—
—
—
—
cases:4.25%
controls:0.96%
cases:8.25%
controls:3.31%
52
226
593
6223
19
59
626
6390
—
—
—
26
59
586
6100
39
158
434
4620
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.1e-01
1.0e+00
2.2e+00
—
1.1e+00
5.7e-01
7.0e-01
cases:13.18%
controls:10.02%
cases:12.87%
controls:5.01%
cases:6.36%
controls:0.71%
—
—
cases:1.87%
controls:0.65%
cases:7.84%
controls:4.58%
cases:24.74%
controls:13.98%
85
646
560
5803
83
323
562
6126
41
46
604
6403
—
12
42
630
6392
48
282
564
5877
117
668
356
4110
Hyperlipidaemia, unspecified
E78.5 [45537986]
1.0e+00
2.4e+00
—
1.0e+50
—
2.0e+00
6.7e-01
cases:0.78%
controls:0.28%
cases:1.55%
controls:0.14%
—
—
cases:0.93%
controls:0.00%
—
—
cases:1.47%
controls:0.19%
cases:1.06%
controls:0.54%
5
18
640
6431
10
9
635
6440
—
6
0
639
6449
—
9
12
603
6147
5
26
468
4752
Inpatient Hospital
21 [8717]
2.4e-01
5.8e-01
1.4e+00
—
1.6e+00
8.3e-01
3.7e-01
cases:28.53%
controls:23.91%
cases:10.54%
controls:6.20%
cases:2.79%
controls:0.71%
—
—
cases:2.80%
controls:0.58%
cases:11.60%
controls:5.41%
cases:20.30%
controls:14.99%
184
1542
461
4907
68
400
577
6049
18
46
627
6403
—
18
37
624
6397
71
333
541
5826
96
716
377
4062
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.9e-01
7.4e-01
2.3e+00
—
1.2e+00
7.2e-01
4.2e-01
cases:13.64%
controls:8.02%
cases:6.67%
controls:3.30%
cases:3.10%
controls:0.31%
—
—
cases:1.09%
controls:0.33%
cases:6.86%
controls:3.47%
cases:15.64%
controls:10.82%
88
517
557
5932
43
213
602
6236
20
20
625
6429
—
7
21
635
6413
42
214
570
5945
74
517
399
4261
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
5.1e-01
2.1e+00
—
—
—
2.2e+00
1.1e+00
cases:0.78%
controls:0.47%
cases:1.24%
controls:0.16%
—
—
—
—
—
—
cases:1.31%
controls:0.15%
cases:2.11%
controls:0.69%
5
30
640
6419
8
10
637
6439
—
—
—
8
9
604
6150
10
33
463
4745
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.1e-01
1.1e+00
2.3e+00
1.0e+50
1.1e+00
5.4e-01
7.5e-01
cases:12.09%
controls:9.15%
cases:11.16%
controls:4.20%
cases:5.89%
controls:0.60%
cases:0.78%
controls:0.00%
cases:1.71%
controls:0.59%
cases:6.70%
controls:4.03%
cases:22.41%
controls:11.99%
78
590
567
5859
72
271
573
6178
38
39
607
6410
5
0
640
6449
11
38
631
6396
41
248
571
5911
106
573
367
4205
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16182-8 [3021952]
2.4e+00
—
—
—
—
—
1.6e+00
cases:1.40%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.33%
9
8
636
6441
—
—
—
—
—
8
16
465
4762
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
1.0e+00
2.3e+00
—
—
—
1.7e+00
9.4e-01
cases:1.55%
controls:0.56%
cases:1.40%
controls:0.14%
—
—
—
—
—
—
cases:1.47%
controls:0.26%
cases:2.33%
controls:0.92%
10
36
635
6413
9
9
636
6440
—
—
—
9
16
603
6143
11
44
462
4734
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
8.3e-01
2.2e+00
—
—
—
1.8e+00
9.6e-01
cases:1.86%
controls:0.82%
cases:2.02%
controls:0.22%
—
—
—
—
—
—
cases:1.96%
controls:0.34%
cases:3.17%
controls:1.23%
12
53
633
6396
13
14
632
6435
—
—
—
12
21
600
6138
15
59
458
4719
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
5.2e-01
1.6e+00
2.4e+00
—
—
8.3e-01
5.4e-01
cases:5.27%
controls:3.21%
cases:5.12%
controls:1.07%
cases:2.02%
controls:0.19%
—
—
—
—
cases:2.61%
controls:1.15%
cases:5.29%
controls:3.16%
34
207
611
6242
33
69
612
6380
13
12
632
6437
—
—
16
71
596
6088
25
151
448
4627
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
2.2e-01
1.9e+00
—
—
—
2.1e+00
1.1e+00
cases:0.93%
controls:0.74%
cases:1.40%
controls:0.20%
—
—
—
—
—
—
cases:1.63%
controls:0.21%
cases:1.90%
controls:0.65%
6
48
639
6401
9
13
636
6436
—
—
—
10
13
602
6146
9
31
464
4747
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
9.0e-01
2.6e+00
—
—
—
1.3e+00
1.4e+00
cases:2.64%
controls:1.09%
cases:4.81%
controls:0.39%
—
—
—
—
—
—
cases:0.98%
controls:0.26%
cases:4.02%
controls:1.05%
17
70
628
6379
31
25
614
6424
—
—
—
6
16
606
6143
19
50
454
4728
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
3.1e-01
1.9e+00
—
—
—
1.2e+00
8.0e-01
cases:4.65%
controls:3.46%
cases:6.36%
controls:1.04%
—
—
—
—
—
—
cases:2.12%
controls:0.63%
cases:4.86%
controls:2.24%
30
223
615
6226
41
67
604
6382
—
—
—
13
39
599
6120
23
107
450
4671
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.1e-01
9.9e-01
2.2e+00
—
—
6.6e-01
6.9e-01
cases:9.30%
controls:6.98%
cases:7.91%
controls:3.10%
cases:2.33%
controls:0.26%
—
—
—
—
cases:5.23%
controls:2.78%
cases:15.22%
controls:8.25%
60
450
585
5999
51
200
594
6249
15
17
630
6432
—
—
32
171
580
5988
72
394
401
4384
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
5.8e-01
—
—
—
—
2.0e+00
1.8e+00
cases:1.24%
controls:0.70%
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.23%
cases:2.96%
controls:0.48%
8
45
637
6404
—
—
—
—
10
14
602
6145
14
23
459
4755
Stomach Pathology biopsy report
66114-0 [40768797]
8.2e-01
1.3e+00
—
—
—
1.6e+00
5.2e-01
cases:5.74%
controls:2.62%
cases:2.02%
controls:0.54%
—
—
—
—
—
—
cases:3.10%
controls:0.65%
cases:4.65%
controls:2.83%
37
169
608
6280
13
35
632
6414
—
—
—
19
40
593
6119
22
135
451
4643
More than three and less than five hours
ZXE20 [2001311408]
2.0e-02
—
—
—
—
2.2e+00
1.6e+00
cases:1.55%
controls:1.52%
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.11%
cases:2.54%
controls:0.54%
10
98
635
6351
—
—
—
—
6
7
606
6152
12
26
461
4752
Anaemia, unspecified
D64.9 [45600610]
1.0e+00
1.9e+00
—
1.0e+50
—
1.8e+00
8.9e-01
cases:1.71%
controls:0.62%
cases:1.55%
controls:0.23%
—
—
cases:0.78%
controls:0.00%
—
—
cases:1.47%
controls:0.24%
cases:2.11%
controls:0.88%
11
40
634
6409
10
15
635
6434
—
5
0
640
6449
—
9
15
603
6144
10
42
463
4736
Electrocardiogram with exercise test
46136006 [4261794]
5.2e-01
1.3e+00
—
—
—
2.3e+00
1.4e+00
cases:1.55%
controls:0.93%
cases:1.24%
controls:0.33%
—
—
—
—
—
—
cases:0.98%
controls:0.10%
cases:2.33%
controls:0.59%
10
60
635
6389
8
21
637
6428
—
—
—
6
6
606
6153
11
28
462
4750
androstanolone
G03BB02 [21602513]
1.2e+00
1.3e+00
—
—
1.8e+00
1.6e+00
1.9e+00
cases:1.71%
controls:0.53%
cases:1.40%
controls:0.40%
—
—
—
—
cases:0.93%
controls:0.16%
cases:1.80%
controls:0.36%
cases:3.38%
controls:0.50%
11
34
634
6415
9
26
636
6423
—
—
6
10
636
6424
11
22
601
6137
16
24
457
4754
Cardiology
6 [38004451]
2.6e-01
5.5e-01
7.7e-01
—
1.3e+00
1.3e+00
8.6e-01
cases:11.32%
controls:8.95%
cases:7.13%
controls:4.25%
cases:1.40%
controls:0.65%
—
—
cases:2.18%
controls:0.61%
cases:13.07%
controls:3.78%
cases:21.35%
controls:10.28%
73
577
572
5872
46
274
599
6175
9
42
636
6407
—
14
39
628
6395
80
233
532
5926
101
491
372
4287
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
5.0e-01
1.7e+00
—
—
—
1.8e+00
6.6e-01
cases:1.71%
controls:1.04%
cases:2.33%
controls:0.45%
—
—
—
—
—
—
cases:1.47%
controls:0.24%
cases:1.69%
controls:0.88%
11
67
634
6382
15
29
630
6420
—
—
—
9
15
603
6144
8
42
465
4736
Other and unspecified cirrhosis of liver
K74.6 [45538546]
—
—
—
1.0e+50
—
—
3.4e+00
—
—
—
—
—
—
cases:1.09%
controls:0.00%
—
—
—
—
cases:3.17%
controls:0.10%
—
—
—
7
0
638
6449
—
—
15
5
458
4773
Standard cardiac ultrasound examination
FM1AE [2001303278]
2.3e-01
6.3e-01
—
—
2.5e+00
1.1e+00
8.8e-01
cases:2.95%
controls:2.36%
cases:1.71%
controls:0.91%
—
—
—
—
cases:0.93%
controls:0.08%
cases:1.96%
controls:0.65%
cases:5.50%
controls:2.37%
19
152
626
6297
11
59
634
6390
—
—
6
5
636
6429
12
40
600
6119
26
113
447
4665
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
6.6e-01
1.4e+00
—
1.0e+50
—
3.4e+00
6.3e-01
cases:1.40%
controls:0.73%
cases:0.93%
controls:0.23%
—
—
cases:2.79%
controls:0.00%
—
—
cases:5.72%
controls:0.21%
cases:1.06%
controls:0.57%
9
47
636
6402
6
15
639
6434
—
18
0
627
6449
—
35
13
577
6146
5
27
468
4751
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
4.5e-01
1.1e+00
1.7e+00
—
—
1.0e+00
1.2e+00
cases:4.03%
controls:2.62%
cases:3.41%
controls:1.12%
cases:1.09%
controls:0.20%
—
—
—
—
cases:2.78%
controls:1.04%
cases:8.67%
controls:2.78%
26
169
619
6280
22
72
623
6377
7
13
638
6436
—
—
17
64
595
6095
41
133
432
4645
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.1e-01
9.9e-01
1.8e+00
—
4.9e-01
5.5e-01
5.4e-01
cases:8.99%
controls:6.73%
cases:7.75%
controls:3.04%
cases:2.95%
controls:0.51%
—
—
cases:0.93%
controls:0.58%
cases:4.74%
controls:2.78%
cases:13.32%
controls:8.25%
58
434
587
6015
50
196
595
6253
19
33
626
6416
—
6
37
636
6397
29
171
583
5988
63
394
410
4384
Abdominal ultrasound examination
JN3AE [2001305555]
8.6e-01
1.4e+00
—
1.0e+50
—
2.2e+00
1.1e+00
cases:2.95%
controls:1.27%
cases:1.24%
controls:0.29%
—
—
cases:1.71%
controls:0.00%
—
—
cases:2.61%
controls:0.29%
cases:3.38%
controls:1.19%
19
82
626
6367
8
19
637
6430
—
11
0
634
6449
—
16
18
596
6141
16
57
457
4721
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.9e-01
8.9e-01
1.5e+00
—
—
8.2e-01
4.4e-01
cases:6.82%
controls:5.71%
cases:4.34%
controls:1.83%
cases:1.40%
controls:0.31%
—
—
—
—
cases:4.25%
controls:1.92%
cases:11.42%
controls:7.64%
44
368
601
6081
28
118
617
6331
9
20
636
6429
—
—
26
118
586
6041
54
365
419
4413
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.2e-01
7.6e-01
1.8e+00
—
1.3e+00
4.1e-01
6.9e-01
cases:9.46%
controls:7.06%
cases:7.75%
controls:3.78%
cases:2.48%
controls:0.43%
—
—
cases:1.40%
controls:0.39%
cases:4.58%
controls:3.08%
cases:16.49%
controls:8.98%
61
455
584
5994
50
244
595
6205
16
28
629
6421
—
9
25
633
6409
28
190
584
5969
78
429
395
4349
Neurology
13 [38004458]
1.9e-01
5.9e-01
9.1e-01
—
1.2e+00
7.3e-01
6.4e-01
cases:9.61%
controls:8.11%
cases:6.36%
controls:3.63%
cases:1.86%
controls:0.76%
—
—
cases:2.02%
controls:0.59%
cases:7.03%
controls:3.52%
cases:15.01%
controls:8.54%
62
523
583
5926
41
234
604
6215
12
49
633
6400
—
13
38
629
6396
43
217
569
5942
71
408
402
4370
Pharmacy visit
OMOP4822462 [581458]
5.9e-01
7.1e-01
3.9e-01
8.7e-01
5.3e-01
6.7e-01
6.6e-01
cases:96.28%
controls:93.49%
cases:90.85%
controls:82.99%
cases:52.87%
controls:43.22%
cases:5.12%
controls:2.20%
cases:57.01%
controls:43.74%
cases:91.01%
controls:83.84%
cases:97.25%
controls:94.83%
621
6029
24
420
586
5352
59
1097
341
2787
304
3662
33
142
612
6307
366
2814
276
3620
557
5164
55
995
460
4531
13
247
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
2.2e-01
8.1e-01
1.9e+00
—
6.3e-01
4.6e-01
2.7e-01
cases:41.09%
controls:35.94%
cases:34.26%
controls:18.86%
cases:12.87%
controls:2.17%
—
—
cases:3.89%
controls:2.11%
cases:27.45%
controls:19.21%
cases:50.32%
controls:43.55%
265
2318
380
4131
221
1216
424
5233
83
140
562
6309
—
25
136
617
6298
168
1183
444
4976
238
2081
235
2697
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
4.0e-01
4.0e-01
2.2e+00
—
—
9.6e-01
4.5e-01
cases:5.74%
controls:3.92%
cases:2.79%
controls:1.89%
cases:1.40%
controls:0.16%
—
—
—
—
cases:3.43%
controls:1.35%
cases:6.98%
controls:4.58%
37
253
608
6196
18
122
627
6327
9
10
636
6439
—
—
21
83
591
6076
33
219
440
4559
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
2.1e-01
7.7e-01
1.9e+00
—
4.8e-01
5.1e-01
2.9e-01
cases:34.57%
controls:30.08%
cases:33.33%
controls:18.81%
cases:14.26%
controls:2.48%
—
—
cases:3.74%
controls:2.35%
cases:29.08%
controls:19.76%
cases:51.16%
controls:43.83%
223
1940
422
4509
215
1213
430
5236
92
160
553
6289
—
24
151
618
6283
178
1217
434
4942
242
2094
231
2684
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.2e-01
6.4e-01
1.3e+00
—
4.9e-01
7.4e-01
3.9e-01
cases:15.97%
controls:13.21%
cases:9.92%
controls:5.49%
cases:2.79%
controls:0.76%
—
—
cases:1.09%
controls:0.67%
cases:10.78%
controls:5.47%
cases:22.83%
controls:16.68%
103
852
542
5597
64
354
581
6095
18
49
627
6400
—
7
43
635
6391
66
337
546
5822
108
797
365
3981
Essential (primary) hypertension
I10 [45591453]
3.1e-01
8.6e-01
8.6e-01
—
1.0e+00
6.6e-01
4.9e-01
cases:18.60%
controls:14.34%
cases:14.88%
controls:6.92%
cases:2.64%
controls:1.13%
—
—
cases:3.12%
controls:1.12%
cases:13.56%
controls:7.50%
cases:29.18%
controls:20.09%
120
925
525
5524
96
446
549
6003
17
73
628
6376
—
20
72
622
6362
83
462
529
5697
138
960
335
3818
Genetic counselling
Z31.5 [45590715]
8.1e-01
—
—
1.0e+50
—
3.0e+00
9.3e-01
cases:1.24%
controls:0.56%
—
—
—
—
cases:1.09%
controls:0.00%
—
—
cases:3.92%
controls:0.19%
cases:1.27%
controls:0.50%
8
36
637
6413
—
—
7
0
638
6449
—
24
12
588
6147
6
24
467
4754
Osmolality of Urine
2695-5 [3026782]
4.7e-01
6.4e-01
3.0e+00
—
—
8.5e-01
6.1e-01
cases:6.20%
controls:3.95%
cases:2.95%
controls:1.58%
cases:1.55%
controls:0.08%
—
—
—
—
cases:2.94%
controls:1.28%
cases:6.55%
controls:3.66%
40
255
605
6194
19
102
626
6347
10
5
635
6444
—
—
18
79
594
6080
31
175
442
4603
Thorax X-ray examination
GD1AA [2001303617]
5.1e-01
8.2e-01
—
1.0e+50
1.3e+00
9.6e-01
7.2e-01
cases:12.09%
controls:7.61%
cases:5.43%
controls:2.47%
—
—
cases:1.55%
controls:0.00%
cases:0.93%
controls:0.25%
cases:6.21%
controls:2.48%
cases:15.43%
controls:8.14%
78
491
567
5958
35
159
610
6290
—
10
0
635
6449
6
16
636
6418
38
153
574
6006
73
389
400
4389
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
5.7e-01
1.1e+00
—
1.0e+50
—
1.5e+00
1.4e+00
cases:1.55%
controls:0.88%
cases:0.93%
controls:0.31%
—
—
cases:0.78%
controls:0.00%
—
—
cases:1.63%
controls:0.36%
cases:2.54%
controls:0.65%
10
57
635
6392
6
20
639
6429
—
5
0
640
6449
—
10
22
602
6137
12
31
461
4747
Upper gastrointestinal surgery
106 [44777669]
3.1e-01
4.2e-01
1.6e+00
1.0e+50
5.2e-01
7.5e-01
5.3e-01
cases:12.40%
controls:9.38%
cases:4.81%
controls:3.21%
cases:1.86%
controls:0.37%
cases:0.78%
controls:0.00%
cases:0.78%
controls:0.47%
cases:6.37%
controls:3.10%
cases:13.74%
controls:8.56%
80
605
565
5844
31
207
614
6242
12
24
633
6425
5
0
640
6449
5
30
637
6404
39
191
573
5968
65
409
408
4369
Clinic/Center
261Q00000X [38004207]
7.4e-01
—
—
—
—
2.8e+00
—
cases:1.55%
controls:0.74%
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.15%
—
—
10
48
635
6401
—
—
—
—
15
9
597
6150
—
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.10%
—
—
—
—
—
—
8
5
465
4773
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
4.7e-01
6.1e-01
—
1.0e+50
—
1.8e+00
1.0e+00
cases:4.96%
controls:3.15%
cases:2.33%
controls:1.27%
—
—
cases:0.93%
controls:0.00%
—
—
cases:5.72%
controls:1.04%
cases:9.51%
controls:3.58%
32
203
613
6246
15
82
630
6367
—
6
0
639
6449
—
35
64
577
6095
45
171
428
4607
Orthopedic Surgery
20 [38004465]
1.4e-01
5.8e-01
6.2e-01
—
1.1e+00
6.5e-01
4.7e-01
cases:17.21%
controls:15.30%
cases:9.46%
controls:5.55%
cases:1.55%
controls:0.84%
—
—
cases:2.34%
controls:0.79%
cases:10.13%
controls:5.57%
cases:23.04%
controls:15.80%
111
987
534
5462
61
358
584
6091
10
54
635
6395
—
15
51
627
6383
62
343
550
5816
109
755
364
4023
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
1.7e+00
2.8e+00
1.0e+50
—
—
—
—
cases:0.78%
controls:0.14%
cases:1.24%
controls:0.08%
cases:1.40%
controls:0.00%
—
—
—
—
—
—
—
—
5
9
640
6440
8
5
637
6444
9
0
636
6449
—
—
—
—
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
7.0e-01
6.3e-01
—
—
—
1.6e+00
1.1e+00
cases:3.10%
controls:1.57%
cases:1.40%
controls:0.74%
—
—
—
—
—
—
cases:2.61%
controls:0.54%
cases:3.59%
controls:1.17%
20
101
625
6348
9
48
636
6401
—
—
—
16
33
596
6126
17
56
456
4722
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
80187-8 [21494670]
1.1e+00
2.7e+00
—
—
—
—
-1.0e+50
cases:0.78%
controls:0.25%
cases:1.40%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
5
16
640
6433
9
6
636
6443
—
—
—
—
0
13
473
4765
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.5e-03
2.0e-01
1.5e+00
—
1.0e+00
6.9e-01
4.6e-01
cases:11.32%
controls:11.27%
cases:4.96%
controls:4.09%
cases:1.86%
controls:0.40%
—
—
cases:0.93%
controls:0.34%
cases:6.54%
controls:3.38%
cases:15.43%
controls:10.32%
73
727
572
5722
32
264
613
6185
12
26
633
6423
—
6
22
636
6412
40
208
572
5951
73
493
400
4285
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
4.7e-01
5.5e-01
—
—
—
1.3e+00
1.4e+00
cases:3.10%
controls:1.95%
cases:1.40%
controls:0.81%
—
—
—
—
—
—
cases:1.96%
controls:0.54%
cases:5.07%
controls:1.32%
20
126
625
6323
9
52
636
6397
—
—
—
12
33
600
6126
24
63
449
4715
Other minor surgical procedure on peripheral vessel or lymphatic system
TPW99 [2001309749]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.15%
—
—
—
—
—
—
10
7
463
4771
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.10%
—
—
—
—
—
—
7
5
466
4773
Thorax extensive CT-examination
GD1BD [2001303621]
7.3e-01
—
—
—
—
2.7e+00
—
cases:0.93%
controls:0.45%
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.08%
—
—
6
29
639
6420
—
—
—
—
7
5
605
6154
—
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]
2.6e+00
—
—
—
—
—
1.6e+00
cases:1.09%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.21%
7
5
638
6444
—
—
—
—
—
5
10
468
4768
oxazepam; oral
N05BA04 [21604569]
4.4e-01
7.0e-01
5.9e-01
—
1.2e+00
6.3e-01
7.6e-01
cases:7.60%
controls:5.02%
cases:4.81%
controls:2.43%
cases:1.09%
controls:0.60%
—
—
cases:2.18%
controls:0.68%
cases:4.58%
controls:2.50%
cases:9.51%
controls:4.69%
49
324
596
6125
31
157
614
6292
7
39
638
6410
—
14
44
628
6390
28
154
584
6005
45
224
428
4554
Medical doctor
Z2221 [2001311556]
3.3e-01
8.3e-01
—
—
—
1.2e+00
1.4e+00
cases:4.96%
controls:3.63%
cases:2.33%
controls:1.02%
—
—
—
—
—
—
cases:2.61%
controls:0.80%
cases:6.77%
controls:1.74%
32
234
613
6215
15
66
630
6383
—
—
—
16
49
596
6110
32
83
441
4695
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.3e-01
7.0e-01
1.4e+00
—
1.0e+00
5.0e-01
4.6e-01
cases:12.56%
controls:10.25%
cases:9.46%
controls:4.95%
cases:2.33%
controls:0.56%
—
—
cases:1.40%
controls:0.51%
cases:6.37%
controls:3.98%
cases:18.60%
controls:12.66%
81
661
564
5788
61
319
584
6130
15
36
630
6413
—
9
33
633
6401
39
245
573
5914
88
605
385
4173
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
6.0e-01
9.5e-01
2.1e+00
—
—
9.9e-01
2.2e-01
cases:6.82%
controls:3.86%
cases:3.26%
controls:1.29%
cases:0.78%
controls:0.09%
—
—
—
—
cases:3.76%
controls:1.43%
cases:5.29%
controls:4.29%
44
249
601
6200
21
83
624
6366
5
6
640
6443
—
—
23
88
589
6071
25
205
448
4573
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
7.0e-01
2.5e+00
—
—
—
-1.0e+50
—
cases:1.24%
controls:0.62%
cases:1.71%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
8
40
637
6409
11
9
634
6440
—
—
—
0
5
612
6154
—
Difficulties in perfomrming procedure
ZXD30 [2001311389]
1.3e+00
—
—
—
—
—
2.5e+00
cases:0.93%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.10%
6
16
639
6433
—
—
—
—
—
6
5
467
4773
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.08%
—
—
—
—
—
—
—
6
5
606
6154
—
Normetanephrine [Moles/volume] in Serum or Plasma
25489-6 [3026179]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.93%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
6
5
639
6444
—
—
—
—
—
Examination and observation for other specified reasons
Z04.8 [45552063]
4.0e-01
1.1e+00
2.5e+00
—
—
6.0e-01
-1.1e-01
cases:2.33%
controls:1.57%
cases:1.40%
controls:0.48%
cases:0.93%
controls:0.08%
—
—
—
—
cases:1.14%
controls:0.63%
cases:1.48%
controls:1.65%
15
101
630
6348
9
31
636
6418
6
5
639
6444
—
—
7
39
605
6120
7
79
466
4699
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
—
—
—
—
—
2.5e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.10%
cases:1.06%
controls:0.17%
—
—
—
—
—
7
6
605
6153
5
8
468
4770
Sedation and analgesia
WX002 [2001310758]
2.7e-01
-1.4e-04
—
—
—
1.5e+00
9.3e-01
cases:3.41%
controls:2.62%
cases:0.78%
controls:0.78%
—
—
—
—
—
—
cases:2.45%
controls:0.54%
cases:4.23%
controls:1.72%
22
169
623
6280
5
50
640
6399
—
—
—
15
33
597
6126
20
82
453
4696
Short blood count panel - Blood
55429-5 [40758558]
-1.2e-01
3.4e-01
1.1e+00
—
7.4e-01
7.0e-01
6.5e-01
cases:5.89%
controls:6.62%
cases:4.65%
controls:3.36%
cases:2.48%
controls:0.82%
—
—
cases:1.56%
controls:0.75%
cases:6.05%
controls:3.10%
cases:13.11%
controls:7.33%
38
427
607
6022
30
217
615
6232
16
53
629
6396
—
10
48
632
6386
37
191
575
5968
62
350
411
4428
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
2.1e-01
6.7e-01
1.3e+00
—
1.1e+00
4.1e-01
5.2e-01
cases:14.42%
controls:12.00%
cases:11.78%
controls:6.42%
cases:2.95%
controls:0.85%
—
—
cases:1.87%
controls:0.62%
cases:8.17%
controls:5.60%
cases:25.16%
controls:16.60%
93
774
552
5675
76
414
569
6035
19
55
626
6394
—
12
40
630
6394
50
345
562
5814
119
793
354
3985
propranolol; oral, parenteral
C07AA05 [21601670]
6.3e-01
1.0e+00
1.1e+00
—
7.0e-01
7.7e-01
4.6e-01
cases:7.91%
controls:4.39%
cases:5.58%
controls:2.11%
cases:1.09%
controls:0.37%
—
—
cases:0.78%
controls:0.39%
cases:4.08%
controls:1.93%
cases:6.55%
controls:4.25%
51
283
594
6166
36
136
609
6313
7
24
638
6425
—
5
25
637
6409
25
119
587
6040
31
203
442
4575
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.5e-01
1.3e-01
1.7e+00
—
1.3e+00
4.9e-01
6.6e-01
cases:8.37%
controls:7.29%
cases:3.10%
controls:2.74%
cases:1.40%
controls:0.25%
—
—
cases:0.78%
controls:0.22%
cases:3.27%
controls:2.03%
cases:12.26%
controls:6.76%
54
470
591
5979
20
177
625
6272
9
16
636
6433
—
5
14
637
6420
20
125
592
6034
58
323
415
4455
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.0e-01
6.5e-01
1.2e+00
—
1.0e+00
4.0e-01
4.9e-01
cases:14.42%
controls:12.13%
cases:11.94%
controls:6.59%
cases:2.95%
controls:0.87%
—
—
cases:1.71%
controls:0.64%
cases:8.17%
controls:5.62%
cases:24.74%
controls:16.79%
93
782
552
5667
77
425
568
6024
19
56
626
6393
—
11
41
631
6393
50
346
562
5813
117
802
356
3976
Hypothyroidism, unspecified
E03.9 [45537945]
5.3e-01
1.1e+00
1.7e+00
1.0e+50
—
1.3e+00
6.1e-01
cases:2.79%
controls:1.66%
cases:2.02%
controls:0.67%
cases:0.78%
controls:0.14%
cases:1.40%
controls:0.00%
—
—
cases:2.61%
controls:0.76%
cases:4.23%
controls:2.34%
18
107
627
6342
13
43
632
6406
5
9
640
6440
9
0
636
6449
—
16
47
596
6112
20
112
453
4666
Right side
ZXA00 [2001311346]
2.0e-01
9.5e-01
—
—
—
1.4e+00
9.3e-01
cases:3.88%
controls:3.19%
cases:1.40%
controls:0.54%
—
—
—
—
—
—
cases:1.80%
controls:0.44%
cases:4.44%
controls:1.80%
25
206
620
6243
9
35
636
6414
—
—
—
11
27
601
6132
21
86
452
4692
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.21%
—
—
—
—
—
—
10
10
463
4768
Hemodialysis
TK800 [2001305768]
1.8e+00
—
—
—
—
2.3e+00
2.3e+00
cases:0.93%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.08%
cases:1.48%
controls:0.15%
6
10
639
6439
—
—
—
—
5
5
607
6154
7
7
466
4771
Catheterisation instruction
TKC22 [2001306021]
—
—
—
—
—
-1.0e+50
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.06%
controls:0.10%
—
—
—
—
—
0
5
612
6154
5
5
468
4773
Malignant neoplasm: Liver cell carcinoma
C22.0 [45552247]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.10%
—
—
—
—
—
—
5
5
468
4773
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 [3024172]
—
2.3e+00
1.0e+50
—
—
—
-1.0e+50
—
—
cases:1.71%
controls:0.17%
cases:0.93%
controls:0.00%
—
—
—
—
—
—
cases:0.00%
controls:0.38%
—
11
11
634
6438
6
0
639
6449
—
—
—
0
18
473
4760
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
1.0e+00
2.3e+00
—
—
—
—
1.4e+00
cases:0.78%
controls:0.28%
cases:0.93%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.25%
5
18
640
6431
6
6
639
6443
—
—
—
—
5
12
468
4766
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
9.7e-01
2.3e+00
—
—
—
—
1.6e+00
cases:0.78%
controls:0.29%
cases:0.93%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.21%
5
19
640
6430
6
6
639
6443
—
—
—
—
5
10
468
4768
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
3.6e-01
6.5e-01
7.9e-01
—
1.7e+00
6.6e-01
6.4e-01
cases:10.54%
controls:7.63%
cases:4.96%
controls:2.65%
cases:1.09%
controls:0.50%
—
—
cases:1.87%
controls:0.36%
cases:5.07%
controls:2.70%
cases:12.47%
controls:6.99%
68
492
577
5957
32
171
613
6278
7
32
638
6417
—
12
23
630
6411
31
166
581
5993
59
334
414
4444
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.8e-01
6.3e-01
1.2e+00
—
1.0e+00
3.7e-01
4.9e-01
cases:14.26%
controls:12.23%
cases:11.63%
controls:6.57%
cases:2.79%
controls:0.87%
—
—
cases:1.71%
controls:0.64%
cases:8.17%
controls:5.76%
cases:24.95%
controls:16.95%
92
789
553
5660
75
424
570
6025
18
56
627
6393
—
11
41
631
6393
50
355
562
5804
118
810
355
3968
Cathetrisation of vein
TPH04 [2001309597]
2.5e-01
8.9e-01
—
1.0e+50
1.7e+00
1.2e+00
1.1e+00
cases:4.03%
controls:3.16%
cases:2.02%
controls:0.84%
—
—
cases:0.93%
controls:0.00%
cases:0.78%
controls:0.14%
cases:2.78%
controls:0.83%
cases:6.77%
controls:2.45%
26
204
619
6245
13
54
632
6395
—
6
0
639
6449
5
9
637
6425
17
51
595
6108
32
117
441
4661
Endocrinology
46 [38004485]
4.1e-01
7.0e-01
1.2e+00
—
1.4e+00
1.3e+00
9.6e-01
cases:4.19%
controls:2.82%
cases:3.10%
controls:1.57%
cases:1.09%
controls:0.34%
—
—
cases:1.09%
controls:0.28%
cases:4.58%
controls:1.30%
cases:7.82%
controls:3.16%
27
182
618
6267
20
101
625
6348
7
22
638
6427
—
7
18
635
6416
28
80
584
6079
37
151
436
4627
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
9.2e-02
6.1e-01
1.6e+00
—
1.3e+00
6.0e-01
3.6e-01
cases:8.22%
controls:7.55%
cases:6.05%
controls:3.38%
cases:1.86%
controls:0.37%
—
—
cases:1.25%
controls:0.34%
cases:5.39%
controls:3.02%
cases:12.26%
controls:8.87%
53
487
592
5962
39
218
606
6231
12
24
633
6425
—
8
22
634
6412
33
186
579
5973
58
424
415
4354
vortioxetine; oral
N06AX26 [44819158]
9.7e-02
7.9e-01
—
—
1.0e+00
1.1e+00
1.1e+00
cases:1.71%
controls:1.55%
cases:1.86%
controls:0.85%
—
—
—
—
cases:0.93%
controls:0.34%
cases:2.45%
controls:0.80%
cases:4.02%
controls:1.40%
11
100
634
6349
12
55
633
6394
—
—
6
22
636
6412
15
49
597
6110
19
67
454
4711
Treatment-related counselling outside office
SPAT1249 [2001700350]
1.6e-01
4.6e-01
—
—
1.5e+00
6.9e-01
4.9e-01
cases:11.32%
controls:9.85%
cases:5.12%
controls:3.29%
—
—
—
—
cases:1.40%
controls:0.31%
cases:5.39%
controls:2.78%
cases:11.42%
controls:7.30%
73
635
572
5814
33
212
612
6237
—
—
9
20
633
6414
33
171
579
5988
54
349
419
4429
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
6.9e-01
1.5e+00
1.8e+00
—
—
5.6e-01
4.3e-01
cases:8.22%
controls:4.30%
cases:6.05%
controls:1.40%
cases:0.93%
controls:0.16%
—
—
—
—
cases:2.29%
controls:1.32%
cases:8.25%
controls:5.50%
53
277
592
6172
39
90
606
6359
6
10
639
6439
—
—
14
81
598
6078
39
263
434
4515
Lipid panel - Serum or Plasma
100898-6 [1761868]
3.0e-01
8.0e-01
1.4e+00
—
5.4e-01
4.4e-01
2.2e-01
cases:14.88%
controls:11.43%
cases:12.56%
controls:6.05%
cases:3.26%
controls:0.82%
—
—
cases:1.09%
controls:0.64%
cases:9.31%
controls:6.22%
cases:21.14%
controls:17.73%
96
737
549
5712
81
390
564
6059
21
53
624
6396
—
7
41
635
6393
57
383
555
5776
100
847
373
3931
MRI examination of bile and pancreas ducts with high intesity magnet
JL5BG [2001305383]
1.3e+00
—
—
—
—
—
2.2e+00
cases:0.93%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
6
16
639
6433
—
—
—
—
—
7
8
466
4770
Testicular hypofunction
E29.1 [45576454]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
—
—
—
—
—
—
7
8
466
4770
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
9.2e-01
2.2e+00
—
—
—
—
—
cases:0.78%
controls:0.31%
cases:1.09%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
5
20
640
6429
7
8
638
6441
—
—
—
—
—
Dysphonia
R49.0 [45558473]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.15%
—
—
—
—
—
—
6
7
467
4771
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
6.3e-01
—
—
—
—
2.2e+00
9.6e-01
cases:1.71%
controls:0.91%
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.11%
cases:2.11%
controls:0.82%
11
59
634
6390
—
—
—
—
6
7
606
6152
10
39
463
4739
valaciclovir; oral
J05AB11 [21603137]
6.6e-01
8.5e-01
2.2e+00
—
—
5.0e-01
1.3e-01
cases:3.57%
controls:1.88%
cases:2.02%
controls:0.87%
cases:0.93%
controls:0.11%
—
—
—
—
cases:1.14%
controls:0.70%
cases:2.54%
controls:2.24%
23
121
622
6328
13
56
632
6393
6
7
639
6442
—
—
7
43
605
6116
12
107
461
4671
Extracorporeal dialysis
Z49.1 [45537649]
2.2e+00
—
—
—
—
-1.0e+50
—
cases:0.93%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
6
7
639
6442
—
—
—
—
0
5
612
6154
—
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
8.7e-01
2.2e+00
—
—
—
—
—
cases:0.78%
controls:0.33%
cases:0.93%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
5
21
640
6428
6
7
639
6442
—
—
—
—
—
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
3.1e-01
2.1e+00
—
—
—
—
5.9e-01
cases:1.24%
controls:0.91%
cases:1.71%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.59%
8
59
637
6390
11
13
634
6436
—
—
—
—
5
28
468
4750
Social worker
Z2446 [2001311559]
7.6e-01
—
—
—
—
—
2.1e+00
cases:1.09%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.21%
7
33
638
6416
—
—
—
—
—
8
10
465
4768
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.2e-01
6.0e-01
1.5e+00
—
8.8e-01
4.1e-01
3.8e-01
cases:8.06%
controls:7.21%
cases:6.51%
controls:3.69%
cases:2.02%
controls:0.47%
—
—
cases:0.93%
controls:0.39%
cases:5.39%
controls:3.65%
cases:13.74%
controls:9.79%
52
465
593
5984
42
238
603
6211
13
30
632
6419
—
6
25
636
6409
33
225
579
5934
65
468
408
4310
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.1e-01
6.9e-01
9.3e-01
—
4.3e-01
3.5e-01
4.5e-01
cases:23.57%
controls:19.96%
cases:16.59%
controls:9.10%
cases:2.95%
controls:1.18%
—
—
cases:1.40%
controls:0.92%
cases:10.95%
controls:7.99%
cases:29.18%
controls:20.85%
152
1287
493
5162
107
587
538
5862
19
76
626
6373
—
9
59
633
6375
67
492
545
5667
138
996
335
3782
Liver disease, unspecified
K76.9 [45572233]
2.1e+00
—
—
—
—
—
—
cases:1.09%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
638
6440
—
—
—
—
—
—
Neutrophils [#/volume] in Blood
26499-4 [3017732]
1.6e-01
1.1e+00
1.5e+00
—
—
1.0e+00
4.0e-01
cases:1.71%
controls:1.46%
cases:2.64%
controls:0.93%
cases:0.93%
controls:0.20%
—
—
—
—
cases:2.94%
controls:1.10%
cases:5.71%
controls:3.89%
11
94
634
6355
17
60
628
6389
6
13
639
6436
—
—
18
68
594
6091
27
186
446
4592
Blood transfusion
WW500 [2001310603]
2.1e+00
—
—
—
—
—
1.4e+00
cases:1.55%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.27%
10
13
635
6436
—
—
—
—
—
5
13
468
4765
Emergency Room Visit
ER [9203]
4.1e-01
6.7e-01
8.4e-01
—
8.9e-01
5.2e-01
4.6e-01
cases:37.05%
controls:28.10%
cases:13.95%
controls:7.69%
cases:2.02%
controls:0.88%
—
—
cases:1.87%
controls:0.78%
cases:12.09%
controls:7.58%
cases:28.54%
controls:20.15%
239
1812
406
4637
90
496
555
5953
13
57
632
6392
—
12
50
630
6384
74
467
538
5692
135
963
338
3815
retinol
S01XA02 [21605128]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.17%
—
—
—
—
—
—
6
8
467
4770
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
—
—
—
—
—
2.0e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.13%
cases:1.06%
controls:0.36%
—
—
—
—
—
6
8
606
6151
5
17
468
4761
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
—
2.0e+00
—
—
—
—
8.3e-01
—
—
cases:1.40%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.65%
—
9
12
636
6437
—
—
—
—
7
31
466
4747
Stomatognathic treatment, basic
SHA02 [2001310406]
3.3e-01
2.0e+00
—
—
—
—
2.6e-01
cases:1.40%
controls:1.01%
cases:0.93%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.82%
9
65
636
6384
6
8
639
6441
—
—
—
—
5
39
468
4739
Pure hypercholesterolaemia
E78.01 [2000501514]
8.1e-01
1.1e+00
—
—
—
1.2e+00
4.8e-01
cases:3.41%
controls:1.55%
cases:1.86%
controls:0.60%
—
—
—
—
—
—
cases:2.61%
controls:0.80%
cases:4.44%
controls:2.80%
22
100
623
6349
12
39
633
6410
—
—
—
16
49
596
6110
21
134
452
4644
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.23%
—
0
13
645
6436
—
—
—
—
8
11
465
4767
Respiratory infection other
R83 [2002000951]
8.0e-02
5.2e-01
2.0e+00
—
-1.0e+50
-2.5e-01
-7.2e-01
cases:6.20%
controls:5.75%
cases:3.72%
controls:2.25%
cases:1.24%
controls:0.17%
—
—
cases:0.00%
controls:0.16%
cases:1.63%
controls:2.08%
cases:3.17%
controls:6.30%
40
371
605
6078
24
145
621
6304
8
11
637
6438
—
0
10
642
6424
10
128
602
6031
15
301
458
4477
pH of Specimen
17433-4 [3019225]
6.7e-01
1.2e+00
2.1e+00
—
—
8.0e-01
8.1e-01
cases:4.03%
controls:2.11%
cases:3.10%
controls:0.98%
cases:0.78%
controls:0.09%
—
—
—
—
cases:1.80%
controls:0.81%
cases:5.50%
controls:2.51%
26
136
619
6313
20
63
625
6386
5
6
640
6443
—
—
11
50
601
6109
26
120
447
4658
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.27%
—
—
—
—
—
—
9
13
464
4765
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
6.3e-01
1.6e+00
—
—
—
2.0e+00
1.2e+00
cases:1.24%
controls:0.67%
cases:0.93%
controls:0.19%
—
—
—
—
—
—
cases:1.47%
controls:0.21%
cases:2.54%
controls:0.77%
8
43
637
6406
6
12
639
6437
—
—
—
9
13
603
6146
12
37
461
4741
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
8.0e-02
4.5e-02
1.9e+00
—
—
5.1e-01
4.2e-01
cases:5.74%
controls:5.32%
cases:2.17%
controls:2.08%
cases:1.40%
controls:0.20%
—
—
—
—
cases:2.78%
controls:1.69%
cases:7.82%
controls:5.30%
37
343
608
6106
14
134
631
6315
9
13
636
6436
—
—
17
104
595
6055
37
253
436
4525
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
9.5e-01
1.9e+00
—
—
—
—
7.1e-01
cases:1.55%
controls:0.60%
cases:1.40%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.52%
10
39
635
6410
9
13
636
6436
—
—
—
—
5
25
468
4753
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
2.8e-01
1.1e+00
2.1e+00
—
—
6.2e-01
8.5e-01
cases:2.02%
controls:1.54%
cases:2.33%
controls:0.79%
cases:0.78%
controls:0.09%
—
—
—
—
cases:1.14%
controls:0.62%
cases:4.44%
controls:1.95%
13
99
632
6350
15
51
630
6398
5
6
640
6443
—
—
7
38
605
6121
21
93
452
4685
Dyspnoea
R06.0 [45558449]
8.4e-01
8.0e-01
1.7e+00
—
—
1.1e+00
3.5e-01
cases:6.36%
controls:2.85%
cases:2.48%
controls:1.13%
cases:0.78%
controls:0.14%
—
—
—
—
cases:3.27%
controls:1.12%
cases:5.92%
controls:4.23%
41
184
604
6265
16
73
629
6376
5
9
640
6440
—
—
20
69
592
6090
28
202
445
4576
Bacteria [Presence] in Urine
87829-8 [36304419]
2.2e-01
6.2e-01
1.9e+00
—
1.1e+00
6.8e-01
3.6e-01
cases:6.51%
controls:5.29%
cases:4.19%
controls:2.29%
cases:1.55%
controls:0.23%
—
—
cases:0.93%
controls:0.31%
cases:4.25%
controls:2.21%
cases:9.09%
controls:6.55%
42
341
603
6108
27
148
618
6301
10
15
635
6434
—
6
20
636
6414
26
136
586
6023
43
313
430
4465
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.9e+00
—
—
—
—
2.0e+00
—
cases:1.24%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.11%
—
—
8
12
637
6437
—
—
—
—
5
7
607
6152
—
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.4e-01
5.4e-01
1.3e+00
—
1.0e-01
1.6e-01
1.7e-01
cases:38.29%
controls:35.15%
cases:26.20%
controls:17.10%
cases:6.82%
controls:1.89%
—
—
cases:1.87%
controls:1.69%
cases:19.77%
controls:17.36%
cases:44.40%
controls:40.31%
247
2267
398
4182
169
1103
476
5346
44
122
601
6327
—
12
109
630
6325
121
1069
491
5090
210
1926
263
2852
Chest pain, unspecified
R07.4 [45558450]
7.1e-01
8.4e-01
—
—
—
1.2e+00
4.7e-01
cases:7.44%
controls:3.81%
cases:2.79%
controls:1.22%
—
—
—
—
—
—
cases:3.76%
controls:1.22%
cases:7.82%
controls:5.02%
48
246
597
6203
18
79
627
6370
—
—
—
23
75
589
6084
37
240
436
4538
Enzyme measurement
122444009 [4046263]
8.9e-01
1.9e+00
—
—
—
—
—
cases:1.24%
controls:0.51%
cases:1.09%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
8
33
637
6416
7
11
638
6438
—
—
—
—
—
Elevated level of transaminase and lactic acid dehydrogenase
274774002 [436238]
1.9e+00
—
—
—
—
—
—
cases:1.09%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
638
6438
—
—
—
—
—
—
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
—
1.9e+00
—
—
—
—
8.4e-01
—
—
cases:1.09%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.46%
—
7
11
638
6438
—
—
—
—
5
22
468
4756
Morphology [Interpretation] in Blood Narrative
18314-5 [3000093]
1.9e+00
—
—
—
—
—
—
cases:1.09%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
638
6438
—
—
—
—
—
—
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.2e-01
5.8e-01
1.3e+00
—
3.5e-01
1.8e-01
1.8e-01
cases:39.84%
controls:36.97%
cases:31.16%
controls:20.25%
cases:7.60%
controls:2.25%
—
—
cases:2.96%
controls:2.11%
cases:24.35%
controls:21.25%
cases:52.01%
controls:47.55%
257
2384
388
4065
201
1306
444
5143
49
145
596
6304
—
19
136
623
6298
149
1309
463
4850
246
2272
227
2506
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.9e-01
6.5e-01
1.8e+00
—
1.1e+00
6.4e-01
4.0e-01
cases:6.36%
controls:5.33%
cases:4.50%
controls:2.39%
cases:1.55%
controls:0.25%
—
—
cases:0.93%
controls:0.31%
cases:4.41%
controls:2.37%
cases:9.94%
controls:6.86%
41
344
604
6105
29
154
616
6295
10
16
635
6433
—
6
20
636
6414
27
146
585
6013
47
328
426
4450
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30522-7 [3010156]
4.5e-01
1.8e+00
—
—
—
8.3e-01
2.5e-01
cases:1.24%
controls:0.79%
cases:2.02%
controls:0.33%
—
—
—
—
—
—
cases:0.82%
controls:0.36%
cases:1.48%
controls:1.15%
8
51
637
6398
13
21
632
6428
—
—
—
5
22
607
6137
7
55
466
4723
Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.21%
—
—
—
—
—
—
—
8
13
604
6146
—
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.2e-01
5.7e-01
1.2e+00
—
2.5e-01
1.6e-01
1.4e-01
cases:40.31%
controls:37.40%
cases:32.09%
controls:21.04%
cases:7.75%
controls:2.37%
—
—
cases:2.80%
controls:2.19%
cases:25.00%
controls:22.05%
cases:51.80%
controls:48.26%
260
2412
385
4037
207
1357
438
5092
50
153
595
6296
—
18
141
624
6293
153
1358
459
4801
245
2306
228
2472
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
-1.7e-02
1.8e+00
—
—
—
—
-1.0e+50
cases:0.93%
controls:0.95%
cases:1.40%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
6
61
639
6388
9
15
636
6434
—
—
—
—
0
39
473
4739
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
—
—
—
—
—
2.3e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.08%
cases:2.11%
controls:0.36%
—
—
—
—
—
5
5
607
6154
10
17
463
4761
Other anxiety disorders
F41 [45571763]
1.8e+00
—
—
—
—
—
-1.0e+50
cases:1.09%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
7
12
638
6437
—
—
—
—
—
0
10
473
4768
CT of urinary organs
KH1AD [2001306328]
1.8e+00
—
—
—
—
—
—
cases:1.09%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
—
7
12
638
6437
—
—
—
—
—
—
Bone marrow biopsy
XW000 [2001310618]
1.8e+00
—
—
—
—
—
—
cases:1.71%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
11
19
634
6430
—
—
—
—
—
—
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
—
—
—
—
—
1.8e+00
-2.2e-01
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.23%
cases:1.06%
controls:1.32%
—
—
—
—
—
8
14
604
6145
5
63
468
4715
Hepatitis B virus surface Ab [Units/volume] in Serum
16935-9 [3023421]
-4.9e-02
1.8e+00
—
—
—
—
1.2e+00
cases:0.93%
controls:0.98%
cases:1.24%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.40%
6
63
639
6386
8
14
637
6435
—
—
—
—
6
19
467
4759
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
1.2e+00
1.8e+00
—
—
—
—
8.4e-01
cases:1.24%
controls:0.39%
cases:1.24%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.46%
8
25
637
6424
8
14
637
6435
—
—
—
—
5
22
468
4756
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
2.2e-01
1.7e+00
—
—
—
8.5e-01
7.1e-01
cases:2.02%
controls:1.63%
cases:2.79%
controls:0.50%
—
—
—
—
—
—
cases:0.98%
controls:0.42%
cases:3.38%
controls:1.70%
13
105
632
6344
18
32
627
6417
—
—
—
6
26
606
6133
16
81
457
4697
Migraine with aura [classical migraine]
G43.1 [45562086]
6.0e-01
1.1e+00
—
—
—
1.7e+00
5.3e-01
cases:1.55%
controls:0.85%
cases:0.78%
controls:0.25%
—
—
—
—
—
—
cases:1.63%
controls:0.29%
cases:1.69%
controls:1.00%
10
55
635
6394
5
16
640
6433
—
—
—
10
18
602
6141
8
48
465
4730
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.8e-01
5.9e-01
1.7e+00
—
9.7e-01
5.7e-01
3.2e-01
cases:7.29%
controls:6.16%
cases:5.27%
controls:2.99%
cases:1.71%
controls:0.31%
—
—
cases:0.93%
controls:0.36%
cases:4.90%
controls:2.83%
cases:10.99%
controls:8.27%
47
397
598
6052
34
193
611
6256
11
20
634
6429
—
6
23
636
6411
30
174
582
5985
52
395
421
4383
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
3.5e-01
1.7e+00
—
—
—
—
5.7e-01
cases:3.10%
controls:2.20%
cases:3.41%
controls:0.64%
—
—
—
—
—
—
—
—
cases:2.75%
controls:1.57%
20
142
625
6307
22
41
623
6408
—
—
—
—
13
75
460
4703
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.36%
—
—
—
—
—
—
9
17
464
4761
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
9.4e-02
5.1e-01
1.2e+00
—
3.2e-01
1.1e-01
1.2e-01
cases:40.78%
controls:38.53%
cases:33.18%
controls:22.92%
cases:8.22%
controls:2.70%
—
—
cases:3.43%
controls:2.50%
cases:26.47%
controls:24.31%
cases:53.91%
controls:50.86%
263
2485
382
3964
214
1478
431
4971
53
174
592
6275
—
22
161
620
6273
162
1497
450
4662
255
2430
218
2348
Immunohistochemistry procedure
117617002 [4035726]
2.2e-01
1.0e+00
—
—
—
1.7e+00
7.6e-01
cases:2.17%
controls:1.75%
cases:1.09%
controls:0.39%
—
—
—
—
—
—
cases:1.80%
controls:0.34%
cases:2.96%
controls:1.40%
14
113
631
6336
7
25
638
6424
—
—
—
11
21
601
6138
14
67
459
4711
Dorsalgia
M54 [45553203]
-5.9e-02
1.7e+00
—
—
—
7.1e-01
5.0e-01
cases:1.55%
controls:1.64%
cases:2.02%
controls:0.39%
—
—
—
—
—
—
cases:1.14%
controls:0.57%
cases:3.17%
controls:1.95%
10
106
635
6343
13
25
632
6424
—
—
—
7
35
605
6124
15
93
458
4685
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
3.6e-01
1.7e+00
—
—
—
1.0e+00
9.8e-01
cases:1.40%
controls:0.98%
cases:2.17%
controls:0.42%
—
—
—
—
—
—
cases:0.82%
controls:0.29%
cases:2.75%
controls:1.05%
9
63
636
6386
14
27
631
6422
—
—
—
5
18
607
6141
13
50
460
4728
General anesthesia, balanced
WX408 [2001310808]
3.0e-01
4.1e-01
—
—
—
1.6e+00
9.2e-01
cases:5.12%
controls:3.85%
cases:0.93%
controls:0.62%
—
—
—
—
—
—
cases:1.80%
controls:0.36%
cases:3.38%
controls:1.38%
33
248
612
6201
6
40
639
6409
—
—
—
11
22
601
6137
16
66
457
4712
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
—
—
—
—
—
1.6e+00
6.1e-01
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.29%
cases:1.90%
controls:1.05%
—
—
—
—
—
9
18
603
6141
9
50
464
4728
Hordeolum
H00.00 [2000502235]
1.6e+00
—
—
—
—
—
—
cases:1.71%
controls:0.34%
—
—
—
—
—
—
—
—
—
—
—
—
11
22
634
6427
—
—
—
—
—
—
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
2.1e-01
4.4e-01
3.8e-01
—
—
8.2e-01
7.3e-01
cases:7.75%
controls:6.36%
cases:4.96%
controls:3.24%
cases:0.93%
controls:0.64%
—
—
—
—
cases:6.70%
controls:3.05%
cases:13.53%
controls:6.99%
50
410
595
6039
32
209
613
6240
6
41
639
6408
—
—
41
188
571
5971
64
334
409
4444
Generalized anxiety disorder
F41.1 [45571764]
—
8.7e-01
—
—
—
1.4e+00
1.5e+00
—
—
cases:0.78%
controls:0.33%
—
—
—
—
—
—
cases:1.14%
controls:0.29%
cases:2.11%
controls:0.46%
—
5
21
640
6428
—
—
—
7
18
605
6141
10
22
463
4756
Cardiodefibrillation
TFP20 [2001303224]
2.8e-01
—
—
—
—
-1.0e+50
1.5e+00
cases:1.09%
controls:0.82%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.90%
controls:0.42%
7
53
638
6396
—
—
—
—
0
8
612
6151
9
20
464
4758
Thrombin time
3243-3 [3036489]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.42%
—
—
—
—
—
—
9
20
464
4758
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.42%
—
—
—
—
—
—
9
20
464
4758
Palpitations
R00.2 [45558446]
6.6e-01
1.5e+00
—
—
—
—
3.5e-01
cases:1.55%
controls:0.81%
cases:1.55%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.48%
controls:1.05%
10
52
635
6397
10
22
635
6427
—
—
—
—
7
50
466
4728
bisoprolol; oral
C07AB07 [21601689]
3.5e-01
4.2e-01
4.7e-01
—
2.4e-01
5.1e-01
5.9e-01
cases:17.21%
controls:12.82%
cases:16.28%
controls:11.34%
cases:4.81%
controls:3.07%
—
—
cases:4.52%
controls:3.59%
cases:17.97%
controls:11.63%
cases:25.16%
controls:15.76%
111
827
534
5622
105
731
540
5718
31
198
614
6251
—
29
231
613
6203
110
716
502
5443
119
753
354
4025
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
2.5e-01
—
—
—
—
1.7e+00
1.5e+00
cases:0.93%
controls:0.73%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.15%
cases:2.33%
controls:0.52%
6
47
639
6402
—
—
—
—
5
9
607
6150
11
25
462
4753
Ambulatory ECG
XF404 [2001303370]
-4.0e-02
1.7e+00
—
—
—
1.5e+00
1.5e+00
cases:0.78%
controls:0.81%
cases:1.09%
controls:0.20%
—
—
—
—
—
—
cases:0.98%
controls:0.23%
cases:2.11%
controls:0.48%
5
52
640
6397
7
13
638
6436
—
—
—
6
14
606
6145
10
23
463
4755
Ileoscopy through colon
UJF30 [2001305028]
4.9e-01
9.6e-01
—
—
—
1.5e+00
3.0e-01
cases:1.86%
controls:1.15%
cases:0.93%
controls:0.36%
—
—
—
—
—
—
cases:1.63%
controls:0.37%
cases:1.90%
controls:1.42%
12
74
633
6375
6
23
639
6426
—
—
—
10
23
602
6136
9
68
464
4710
Abdominal CT examination
JN3AD [2001305554]
1.4e-01
1.5e+00
—
—
—
7.6e-01
4.1e-01
cases:1.09%
controls:0.95%
cases:2.02%
controls:0.47%
—
—
—
—
—
—
cases:1.31%
controls:0.62%
cases:3.38%
controls:2.28%
7
61
638
6388
13
30
632
6419
—
—
—
8
38
604
6121
16
109
457
4669
Oral Surgery
19 [38004464]
-8.1e-02
—
—
—
—
7.4e-01
1.5e+00
cases:0.93%
controls:1.01%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.39%
cases:1.90%
controls:0.44%
6
65
639
6384
—
—
—
—
5
24
607
6135
9
21
464
4757
Cardiac arrhythmia, unspecified
I49.9 [45581778]
3.6e-01
—
—
—
—
1.5e+00
4.8e-01
cases:1.86%
controls:1.30%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.45%
cases:2.75%
controls:1.72%
12
84
633
6365
—
—
—
—
12
28
600
6131
13
82
460
4696
Other specified counselling
Z71.8 [45581061]
1.7e-01
5.9e-01
1.5e+00
—
1.2e+00
4.8e-01
1.4e-01
cases:6.20%
controls:5.27%
cases:4.19%
controls:2.36%
cases:1.40%
controls:0.33%
—
—
cases:1.09%
controls:0.33%
cases:3.76%
controls:2.37%
cases:9.51%
controls:8.37%
40
340
605
6109
27
152
618
6297
9
21
636
6428
—
7
21
635
6413
23
146
589
6013
45
400
428
4378
Eyelid symptom/complaint
F16 [2002000407]
—
—
—
—
—
-1.0e+50
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:2.54%
controls:0.61%
—
—
—
—
—
0
9
612
6150
12
29
461
4749
Physiotherapist
Z3226 [2001311560]
4.6e-01
6.2e-01
—
—
—
1.5e+00
1.4e+00
cases:2.48%
controls:1.58%
cases:0.78%
controls:0.42%
—
—
—
—
—
—
cases:1.31%
controls:0.31%
cases:4.02%
controls:0.98%
16
102
629
6347
5
27
640
6422
—
—
—
8
19
604
6140
19
47
454
4731
Gas panel - Venous blood
24339-4 [3000991]
1.2e-01
1.4e+00
—
—
—
5.5e-01
1.6e-01
cases:1.09%
controls:0.96%
cases:1.71%
controls:0.42%
—
—
—
—
—
—
cases:0.98%
controls:0.57%
cases:1.90%
controls:1.63%
7
62
638
6387
11
27
634
6422
—
—
—
6
35
606
6124
9
78
464
4700
Ventricular premature depolarization
I49.3 [45538386]
—
—
—
—
—
1.4e+00
2.8e-01
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.41%
cases:1.27%
controls:0.96%
—
—
—
—
—
10
25
602
6134
6
46
467
4732
codeine and paracetamol
N02AJ06 [1123647]
3.3e-01
7.9e-01
8.3e-01
—
6.5e-01
2.6e-01
5.9e-01
cases:20.31%
controls:15.54%
cases:11.01%
controls:5.33%
cases:1.86%
controls:0.82%
—
—
cases:1.71%
controls:0.90%
cases:6.86%
controls:5.36%
cases:22.41%
controls:13.83%
131
1002
514
5447
71
344
574
6105
12
53
633
6396
—
11
58
631
6376
42
330
570
5829
106
661
367
4117
Inpatient Visit
IP [9201]
1.2e-01
3.1e-01
—
—
—
8.5e-01
5.2e-01
cases:7.60%
controls:6.82%
cases:3.88%
controls:2.88%
—
—
—
—
—
—
cases:6.05%
controls:2.68%
cases:13.11%
controls:8.25%
49
440
596
6009
25
186
620
6263
—
—
—
37
165
575
5994
62
394
411
4384
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
5.4e-01
1.5e+00
—
—
—
1.7e+00
1.4e+00
cases:0.93%
controls:0.54%
cases:1.09%
controls:0.25%
—
—
—
—
—
—
cases:1.14%
controls:0.21%
cases:2.33%
controls:0.61%
6
35
639
6414
7
16
638
6433
—
—
—
7
13
605
6146
11
29
462
4749
Other healthcare associate professional
Z3229 [2001311561]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.33%
controls:0.61%
—
—
—
—
—
—
11
29
462
4749
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
5.0e-01
1.4e+00
—
—
—
9.3e-01
1.8e-01
cases:2.17%
controls:1.33%
cases:2.02%
controls:0.53%
—
—
—
—
—
—
cases:0.82%
controls:0.32%
cases:1.90%
controls:1.59%
14
86
631
6363
13
34
632
6415
—
—
—
5
20
607
6139
9
76
464
4702
Weakness/tiredness general
A04 [2002000145]
2.5e-01
1.3e+00
—
—
—
8.0e-01
1.7e-01
cases:1.86%
controls:1.46%
cases:1.86%
controls:0.50%
—
—
—
—
—
—
cases:1.80%
controls:0.81%
cases:2.54%
controls:2.16%
12
94
633
6355
12
32
633
6417
—
—
—
11
50
601
6109
12
103
461
4675
Pain in joint
M25.5 [45586941]
5.5e-01
7.1e-01
1.0e+00
—
1.0e+00
7.8e-01
5.1e-01
cases:8.22%
controls:4.93%
cases:4.03%
controls:2.02%
cases:0.78%
controls:0.28%
—
—
cases:0.78%
controls:0.28%
cases:4.58%
controls:2.14%
cases:10.78%
controls:6.78%
53
318
592
6131
26
130
619
6319
5
18
640
6431
—
5
18
637
6416
28
132
584
6027
51
324
422
4454
Extensive body CT
JN4BD [2001310899]
—
2.8e-01
—
—
-1.0e+50
—
1.3e+00
—
—
cases:0.78%
controls:0.59%
—
—
—
—
cases:0.00%
controls:0.08%
—
—
cases:2.75%
controls:0.75%
—
5
38
640
6411
—
—
0
5
642
6429
—
13
36
460
4742
amitriptyline; oral, parenteral
N06AA09 [21604696]
6.0e-01
5.5e-01
1.0e+00
—
1.2e+00
6.7e-01
6.9e-01
cases:7.13%
controls:4.03%
cases:3.88%
controls:2.26%
cases:1.09%
controls:0.40%
—
—
cases:1.87%
controls:0.58%
cases:3.76%
controls:1.96%
cases:8.46%
controls:4.42%
46
260
599
6189
25
146
620
6303
7
26
638
6423
—
12
37
630
6397
23
121
589
6038
40
211
433
4567
Primary total prosthetic replacement of hip joint not using cement
NFB30 [2001307921]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.77%
—
—
—
—
—
—
13
37
460
4741
Pain localized to upper abdomen
R10.1 [45568111]
5.7e-01
9.0e-01
—
—
—
1.3e+00
5.4e-01
cases:3.57%
controls:2.05%
cases:1.71%
controls:0.70%
—
—
—
—
—
—
cases:2.29%
controls:0.65%
cases:4.44%
controls:2.64%
23
132
622
6317
11
45
634
6404
—
—
—
14
40
598
6119
21
126
452
4652
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
5.1e-01
1.3e+00
—
—
—
9.3e-01
2.0e-01
cases:2.33%
controls:1.41%
cases:2.02%
controls:0.57%
—
—
—
—
—
—
cases:0.98%
controls:0.39%
cases:2.11%
controls:1.74%
15
91
630
6358
13
37
632
6412
—
—
—
6
24
606
6135
10
83
463
4695
Skin Pathology biopsy report
65754-4 [40768443]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.80%
—
—
—
—
—
—
13
38
460
4740
Person consulting for explanation of investigation findings
Z71.2 [45552100]
4.0e-01
1.2e+00
—
—
—
3.7e-01
1.0e-01
cases:5.89%
controls:4.03%
cases:4.65%
controls:1.40%
—
—
—
—
—
—
cases:2.29%
controls:1.59%
cases:7.61%
controls:6.91%
38
260
607
6189
30
90
615
6359
—
—
—
14
98
598
6061
36
330
437
4448
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
6.0e-01
5.3e-01
—
—
—
2.0e-01
6.2e-01
cases:8.37%
controls:4.78%
cases:2.02%
controls:1.19%
—
—
—
—
—
—
cases:1.31%
controls:1.07%
cases:8.03%
controls:4.48%
54
308
591
6141
13
77
632
6372
—
—
—
8
66
604
6093
38
214
435
4564
esomeprazole; oral, parenteral
A02BC05 [21600100]
5.0e-01
7.0e-01
5.3e-01
—
7.2e-01
4.7e-01
4.5e-01
cases:12.25%
controls:7.78%
cases:7.60%
controls:3.91%
cases:1.55%
controls:0.91%
—
—
cases:1.71%
controls:0.84%
cases:6.37%
controls:4.09%
cases:11.21%
controls:7.47%
79
502
566
5947
49
252
596
6197
10
59
635
6390
—
11
54
631
6380
39
252
573
5907
53
357
420
4421
Disease/condition unspecnature/site
A99 [2002000232]
-2.1e-01
2.8e-01
—
—
—
5.0e-01
1.2e+00
cases:0.93%
controls:1.15%
cases:0.78%
controls:0.59%
—
—
—
—
—
—
cases:1.14%
controls:0.70%
cases:4.23%
controls:1.32%
6
74
639
6375
5
38
640
6411
—
—
—
7
43
605
6116
20
63
453
4715
One hour or less
ZXE00 [2001311394]
4.2e-01
7.6e-01
—
—
—
8.9e-01
1.2e+00
cases:8.37%
controls:5.64%
cases:2.64%
controls:1.26%
—
—
—
—
—
—
cases:2.61%
controls:1.09%
cases:9.30%
controls:3.03%
54
364
591
6085
17
81
628
6368
—
—
—
16
67
596
6092
44
145
429
4633
hydrocortisone; oral, parenteral
H02AB09 [21602737]
5.4e-01
6.6e-01
—
—
—
1.0e+00
1.2e+00
cases:2.33%
controls:1.36%
cases:0.78%
controls:0.40%
—
—
—
—
—
—
cases:1.14%
controls:0.41%
cases:3.59%
controls:1.15%
15
88
630
6361
5
26
640
6423
—
—
—
7
25
605
6134
17
55
456
4723
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
1.2e+00
1.6e+00
—
—
—
1.3e+00
4.1e-01
cases:2.48%
controls:0.79%
cases:1.09%
controls:0.22%
—
—
—
—
—
—
cases:0.82%
controls:0.23%
cases:1.48%
controls:0.98%
16
51
629
6398
7
14
638
6435
—
—
—
5
14
607
6145
7
47
466
4731
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
-7.6e-02
7.0e-01
—
—
—
1.0e+00
1.1e+00
cases:2.02%
controls:2.17%
cases:1.09%
controls:0.54%
—
—
—
—
—
—
cases:1.47%
controls:0.52%
cases:3.81%
controls:1.28%
13
140
632
6309
7
35
638
6414
—
—
—
9
32
603
6127
18
61
455
4717
FEV1 --post bronchodilation
20155-8 [3023550]
-7.6e-02
7.0e-01
—
—
—
1.0e+00
1.1e+00
cases:2.02%
controls:2.17%
cases:1.09%
controls:0.54%
—
—
—
—
—
—
cases:1.47%
controls:0.52%
cases:3.81%
controls:1.28%
13
140
632
6309
7
35
638
6414
—
—
—
9
32
603
6127
18
61
455
4717
FVC percent change Respiratory system
69982-7 [42868471]
-7.6e-02
7.0e-01
—
—
—
1.0e+00
1.1e+00
cases:2.02%
controls:2.17%
cases:1.09%
controls:0.54%
—
—
—
—
—
—
cases:1.47%
controls:0.52%
cases:3.81%
controls:1.28%
13
140
632
6309
7
35
638
6414
—
—
—
9
32
603
6127
18
61
455
4717
FEV1/FVC --post bronchodilation
69970-2 [42868459]
-7.6e-02
7.0e-01
—
—
—
1.0e+00
1.1e+00
cases:2.02%
controls:2.17%
cases:1.09%
controls:0.54%
—
—
—
—
—
—
cases:1.47%
controls:0.52%
cases:3.81%
controls:1.28%
13
140
632
6309
7
35
638
6414
—
—
—
9
32
603
6127
18
61
455
4717
FEV1 percent change
69983-5 [42868472]
-7.6e-02
7.0e-01
—
—
—
1.0e+00
1.1e+00
cases:2.02%
controls:2.17%
cases:1.09%
controls:0.54%
—
—
—
—
—
—
cases:1.47%
controls:0.52%
cases:3.81%
controls:1.28%
13
140
632
6309
7
35
638
6414
—
—
—
9
32
603
6127
18
61
455
4717
Intravenous general anesthesia
WX404 [2001310807]
4.0e-02
8.5e-01
—
—
—
8.8e-01
1.1e+00
cases:3.26%
controls:3.13%
cases:1.55%
controls:0.67%
—
—
—
—
—
—
cases:0.82%
controls:0.34%
cases:2.96%
controls:1.00%
21
202
624
6247
10
43
635
6406
—
—
—
5
21
607
6138
14
48
459
4730
Obstetrics / Gynecology
16 [38004461]
1.6e-01
1.0e-01
9.5e-01
—
1.1e+00
2.7e-01
4.6e-01
cases:14.11%
controls:12.33%
cases:5.27%
controls:4.78%
cases:1.55%
controls:0.60%
—
—
cases:2.02%
controls:0.68%
cases:5.39%
controls:4.16%
cases:13.95%
controls:9.27%
91
795
554
5654
34
308
611
6141
10
39
635
6410
—
13
44
629
6390
33
256
579
5903
66
443
407
4335
More than one and less than three hours
ZXE10 [2001311401]
3.2e-01
4.6e-01
—
—
—
1.1e+00
7.4e-01
cases:6.98%
controls:5.16%
cases:1.86%
controls:1.18%
—
—
—
—
—
—
cases:2.29%
controls:0.78%
cases:5.29%
controls:2.60%
45
333
600
6116
12
76
633
6373
—
—
—
14
48
598
6111
25
124
448
4654
Cystoscopy
UKC02 [2001306005]
2.9e-01
—
—
—
-1.0e+50
—
1.1e+00
cases:2.48%
controls:1.88%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
cases:4.23%
controls:1.47%
16
121
629
6328
—
—
—
0
5
642
6429
—
20
70
453
4708
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
3.5e-01
4.3e-01
—
—
—
8.9e-01
1.1e+00
cases:1.86%
controls:1.32%
cases:1.24%
controls:0.81%
—
—
—
—
—
—
cases:1.80%
controls:0.75%
cases:4.44%
controls:1.55%
12
85
633
6364
8
52
637
6397
—
—
—
11
46
601
6113
21
74
452
4704
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.3e-01
6.6e-01
1.1e+00
—
1.3e+00
1.1e+00
3.6e-01
cases:4.96%
controls:4.37%
cases:3.88%
controls:2.05%
cases:1.24%
controls:0.40%
—
—
cases:1.40%
controls:0.37%
cases:5.88%
controls:2.09%
cases:8.67%
controls:6.20%
32
282
613
6167
25
132
620
6317
8
26
637
6423
—
9
24
633
6410
36
129
576
6030
41
296
432
4482

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
510
696
31.06
307.65
8.0
2.3
43.22
23.87
%
66.64
497
659
520
764
30.77
307.65
8.1
2.3
2.16
2.35
g/l
11.71
500
714
520
825
28.19
307.65
8.3
2.3
22.73
13.94
umol/l
69.73
506
778
592
2565
16.65
140.36
13.0
2.8
237.59
133.70
ug/l
8.67
576
2423
343
1275
4.60
81.67
3.8
2.1
2.38
3.00
mg/l
6.44
309
1114
187
503
4.82
65.95
3.0
2.5
0.24
0.22
g/l
2.72
178
472
396
1888
3.84
61.15
4.0
3.2
33.08
33.49
u/l
0.09
376
1793
428
2248
3.68
54.75
6.5
5.0
37.18
36.24
g/l
3.27
406
2123
476
2862
3.52
45.19
8.3
6.7
13.30
11.31
umol/l
1.62
468
2748
476
2882
3.48
44.24
6.9
6.7
1.93
1.96
e9/l
0.13
432
2586
469
2823
3.41
43.83
6.8
6.6
0.56
0.58
e9/l
1.27
417
2453
469
2831
3.40
43.45
6.8
6.6
0.04
0.04
e9/l
0.03
418
2458
474
2920
3.34
41.56
7.0
6.9
0.19
0.19
e9/l
0.11
430
2590
446
2658
3.19
41.32
6.9
6.7
30.97
28.03
%
8.20
426
2529
438
2591
3.14
40.98
7.0
6.8
0.75
0.70
%
1.29
417
2429
437
2599
3.11
40.15
7.1
6.8
9.02
8.90
%
0.46
415
2445
436
2597
3.09
39.81
7.0
6.7
3.06
2.91
%
0.74
415
2441
436
2607
3.07
39.33
6.7
6.6
53.99
56.97
%
7.30
423
2496
85
183
5.20
38.06
1.3
1.2
96.00
107.06
titre
—
10
17
340
1813
2.85
37.40
6.5
6.6
—
—
—
0
0
579
4187
4.69
36.52
11.9
8.1
78.90
78.15
u/l
0.16
566
3985
400
2343
2.86
36.37
13.5
11.6
1.18
1.19
inr
0.33
349
1948
100
278
4.07
32.33
2.0
1.7
0.34
0.36
mg/l
0.10
49
126
268
1344
2.70
32.02
4.9
4.9
—
—
—
0
0
190
800
2.95
31.70
1.5
1.4
595.12
467.64
titre
0.35
41
178
473
3157
2.86
31.22
9.1
10.1
3.56
4.02
e9/l
5.49
424
2767
137
501
3.20
29.04
2.2
2.1
357.05
362.03
nmol/l
0.12
130
477
144
543
3.13
28.96
3.5
3.0
2.00
1.75
%
1.44
131
499
251
1308
2.50
26.68
5.7
3.8
89.80
91.28
%
0.41
243
1282
117
417
3.21
25.70
3.8
3.2
84.76
69.87
e9/l
2.44
87
322
528
3941
2.86
24.40
5.4
3.2
58.95
46.27
u/l
2.47
513
3745
128
497
2.96
24.14
2.4
2.8
10.96
10.49
g/l
0.71
117
466
110
393
3.17
23.98
1.5
1.7
0.95
1.31
g/l
2.53
100
363
256
1409
2.35
23.46
2.5
3.0
621.75
877.85
ng/l
1.21
203
1179
380
2470
2.31
23.43
16.8
10.3
0.00
0.00
e9/l
0.51
318
2045
379
2526
2.21
21.11
10.0
7.0
1.22
1.21
mmol/l
1.01
320
2174
340
2245
2.09
18.50
8.6
6.5
1.22
1.21
mmol/l
0.96
314
2066
114
478
2.68
18.30
4.1
5.7
0.09
0.18
%
0.48
23
127
113
474
2.68
18.11
4.1
5.2
0.00
0.14
%
3.49
25
136
352
2384
2.05
17.54
3.0
2.4
73.20
76.75
nmol/l
1.57
320
2158
116
502
2.60
17.43
4.1
5.1
0.41
0.99
%
2.65
27
162
107
447
2.67
17.25
3.3
3.3
—
—
—
0
0
111
476
2.61
16.96
3.7
5.0
1.70
0.59
%
0.39
27
150
524
4165
2.37
16.61
5.1
3.9
14.71
14.67
pmol/l
0.15
486
3847
205
1163
2.12
16.30
1.6
1.5
2.54
2.49
g/l
0.13
158
757
236
1432
2.02
15.49
3.0
2.5
358.40
341.87
umol/l
1.78
214
1275
216
1281
2.03
15.03
1.4
1.3
1.24
1.47
u/ml
0.15
63
372
61
203
3.21
14.78
1.6
2.3
1.21
1.50
g/l
1.56
49
180
332
2293
1.92
14.69
2.3
2.0
97.04
98.18
pmol/l
0.17
181
1229
128
626
2.30
14.55
4.4
2.7
8.71
7.96
umol/l
0.14
121
557
39
97
4.21
14.46
1.2
1.2
14.70
37.80
u/l
1.04
34
83
147
765
2.19
14.37
2.0
1.6
1249.64
1219.26
nmol/l
0.14
117
595
234
1477
1.92
13.27
6.4
3.8
7.40
7.40
ph
0.10
173
1072
232
1469
1.90
12.97
2.0
1.6
19.52
19.83
nmol/l
0.09
184
1245
24
44
5.63
12.67
1.3
1.3
—
—
—
0
0
580
5032
2.49
11.65
6.5
4.7
1.94
1.88
mu/l
0.41
544
4658
129
691
2.08
11.49
1.8
1.6
—
—
—
0
0
145
813
2.01
11.40
4.6
3.6
0.81
0.83
mmol/l
1.11
136
779
122
643
2.11
11.34
2.8
2.4
14.89
14.03
nmol/l
0.59
108
604
28
68
4.26
10.71
2.4
2.6
34.79
32.60
pg
2.08
28
68
254
1737
1.76
10.57
3.3
2.4
59.32
63.33
u/l
0.35
236
1621
243
1642
1.77
10.53
3.5
2.7
0.03
0.06
estimate
0.25
106
483
66
282
2.49
10.02
3.0
3.3
4.58
4.52
pmol/l
0.22
55
254
115
621
2.04
9.94
10.3
5.5
1.03
1.01
mmol/l
0.48
106
584
160
977
1.85
9.58
2.8
2.5
531.95
556.76
mosm/kgh2o
0.62
148
851
150
900
1.87
9.48
1.9
1.7
—
—
—
0
0
277
1995
1.68
9.22
4.2
3.1
24.83
78.96
ng/l
0.89
189
1339
457
3756
1.74
9.17
4.8
4.0
—
2.60
—
0
6
27
72
3.87
9.14
2.4
2.3
0.85
0.95
%
0.41
13
54
161
1002
1.81
9.00
2.0
1.7
430.04
36830257.43
pmol/l
1.07
131
858
251
1775
1.68
8.87
3.4
3.5
2.35
2.35
mmol/l
0.16
228
1621
392
3115
1.66
8.70
6.5
4.8
6.68
6.56
mmol/l
0.55
377
2951
20
44
4.66
8.64
1.3
1.0
—
—
—
0
0
18
37
4.98
8.40
1.0
1.1
—
—
—
0
0
233
1647
1.65
8.08
4.1
3.5
0.00
0.00
estimate
0.80
117
564
584
5245
2.18
8.07
7.3
5.6
37.06
38.50
mmol/mol
4.40
562
4953
220
1544
1.64
7.79
2.1
2.1
152.89
238.57
u/l
0.86
209
1471
34
119
2.96
7.59
1.5
1.5
—
—
—
0
0
600
5487
2.31
7.25
20.1
13.6
18.73
23.79
mg/l
4.08
516
4433
296
2273
1.56
6.99
3.7
3.2
0.00
0.01
estimate
0.78
107
504
30
103
3.01
6.94
2.7
3.4
3.83
4.19
e9/l
0.35
30
103
363
2926
1.55
6.83
3.9
3.4
0.01
0.00
estimate
0.50
120
604
76
404
2.00
6.79
4.0
3.2
1.23
1.23
mmol/l
0.23
61
349
120
743
1.76
6.67
1.3
1.2
—
—
—
0
0
116
713
1.76
6.61
2.9
3.4
3.47
4.75
e9/l
2.58
94
639
358
2891
1.53
6.58
4.0
3.4
0.00
0.00
estimate
0.50
119
595
161
1087
1.64
6.47
1.3
1.3
33.87
34.95
iu/ml
0.03
31
322
172
1181
1.62
6.46
2.7
2.3
4.29
5.59
e6/l
0.72
159
1079
586
5359
2.01
6.30
6.2
4.7
5.87
5.87
mmol/l
0.02
553
4953
30
111
2.79
6.10
1.6
1.5
166.67
164.50
au/ml
—
6
31
63
326
2.03
6.07
5.8
3.7
85.30
84.65
ng/l
0.02
53
288
357
2937
1.48
5.63
4.0
3.4
0.00
0.53
estimate
0.50
115
571
82
477
1.82
5.59
3.5
3.7
7.37
7.34
ph
0.35
59
340
170
1200
1.57
5.59
1.8
1.7
1.23
1.17
mg/l
0.11
137
936
32
129
2.56
5.53
2.7
3.4
55.94
56.91
%
0.17
32
129
17
47
3.69
5.51
1.0
1.0
—
—
—
0
0
27
103
2.69
5.21
1.4
1.9
0.49
0.77
g/l
0.86
21
81
145
1005
1.57
5.12
1.3
1.3
12.34
12.77
u/ml
0.02
62
414
45
222
2.10
4.94
1.2
1.3
—
—
—
0
0
250
1962
1.45
4.80
4.2
3.5
55.23
89.91
e6/l
0.64
195
1403
62
348
1.86
4.74
1.4
2.5
—
—
—
0
0
43
213
2.09
4.68
1.5
1.5
—
18.93
—
0
7
47
243
2.01
4.57
1.9
2.1
10.70
8.20
iu/ml
—
8
60
601
5639
1.94
4.56
22.9
15.2
139.72
139.80
mmol/l
0.37
594
5532
602
5652
1.96
4.55
23.2
15.4
3.97
3.97
mmol/l
0.21
595
5531
196
1482
1.46
4.52
3.3
2.9
0.46
0.42
e6/l
0.06
154
1087
45
234
1.99
4.32
1.2
1.2
—
2.11
—
0
14
50
270
1.92
4.31
2.2
1.9
35.84
39.98
nmol/l
1.03
50
263
10
16
6.33
4.30
1.4
1.7
—
—
—
0
0
221
1726
1.43
4.24
3.5
3.0
18.60
86.29
e6/l
1.10
182
1338
63
369
1.78
4.22
1.2
1.2
201.67
148.92
u/ml
0.30
26
158
182
1376
1.45
4.15
3.0
2.7
—
—
—
0
0
33
157
2.16
4.01
1.3
1.4
318.21
270.64
ug/g
0.56
19
98
9
14
6.50
3.99
4.9
3.5
3.33
5.85
ug/l
—
9
14
217
1710
1.41
3.90
4.5
3.9
8.16
5.98
mg/mmol
0.47
134
1037
25
108
2.37
3.80
2.2
4.8
3435.63
456.71
u/ml
0.42
25
102
290
2411
1.37
3.73
2.0
1.9
1.46
1.35
mmol/l
1.21
227
2054
39
204
1.97
3.71
1.4
1.3
—
—
—
0
0
212
1676
1.39
3.71
3.7
3.3
43.55
35.90
mg/l
0.30
134
1059
15
50
3.05
3.71
2.1
2.6
1.28
0.81
g/24h
—
10
28
40
212
1.95
3.67
1.3
1.3
—
—
—
0
0
72
457
1.65
3.63
1.5
1.5
—
—
—
0
0
15
51
2.99
3.59
1.0
1.4
—
—
—
0
0
24
106
2.31
3.49
4.2
3.2
—
—
—
0
0
32
160
2.05
3.45
1.6
4.0
37.64
31.16
mg/l
0.56
27
140
32
160
2.05
3.45
1.6
4.0
43.29
72.27
mg/l
0.36
27
137
289
2422
1.35
3.45
3.4
2.9
—
—
—
0
0
394
3461
1.35
3.44
4.6
4.1
1124.00
607.89
e6/l
—
7
47
82
546
1.57
3.41
9.9
9.8
0.80
0.94
mmol/l
0.12
72
450
225
1820
1.36
3.36
3.8
3.2
8.10
8.38
mmol/l
0.36
186
1523
55
332
1.72
3.35
3.9
3.6
7.41
7.42
ph
0.22
48
283
21
89
2.41
3.35
4.1
2.4
8.84
6.54
pmol/l
0.85
21
89
216
1738
1.36
3.33
3.3
2.3
—
—
—
0
0
588
5556
1.65
3.32
5.6
4.8
4.54
4.69
mmol/l
3.62
563
5224
586
5537
1.63
3.25
5.5
4.7
1.39
1.45
mmol/l
3.57
559
5166
82
553
1.55
3.23
10.0
9.8
7.41
7.42
ph
0.28
51
322
92
637
1.52
3.22
1.7
1.6
—
—
—
0
0
616
5904
1.93
3.20
18.2
11.2
31.30
27.61
u/l
5.16
610
5752
8
15
5.39
3.20
1.1
1.2
—
—
—
0
0
11
29
3.84
3.19
2.1
3.6
56.27
117.86
nmol/l
0.61
11
29
53
323
1.70
3.13
3.2
3.0
165.67
162.02
ng/l
0.03
45
293
35
189
1.90
3.07
1.8
1.3
3.65
7.08
u/l
4.94
28
157
562
5274
1.50
3.07
4.7
4.0
1.34
1.28
mmol/l
1.37
530
4895
27
133
2.08
3.05
1.3
1.2
221.83
269.35
u/ml
0.30
12
80
140
1064
1.40
3.02
2.0
1.9
—
—
—
0
0
602
5743
1.71
3.00
23.2
12.1
—
—
—
0
0
102
734
1.46
2.96
1.3
1.3
—
—
—
0
0
19
82
2.36
2.94
1.1
1.1
7.98
4.28
u/ml
—
7
34
70
467
1.56
2.91
1.4
1.4
—
—
—
0
0
7
13
5.43
2.87
3.7
5.2
47.36
48.92
%
—
7
13
16
65
2.50
2.81
1.3
1.4
—
—
—
0
0
16
65
2.50
2.81
1.5
1.3
—
—
—
0
0
16
65
2.50
2.81
1.5
1.2
—
—
—
0
0
132
1007
1.39
2.78
2.5
2.9
2.44
2.44
mmol/l
0.27
115
911
43
258
1.71
2.72
6.9
4.6
24.60
24.38
mmol/l
0.14
43
258
271
2312
1.30
2.66
3.1
3.1
6.05
6.16
ph
1.08
164
1379
590
5627
1.56
2.62
6.3
5.3
2.68
2.79
mmol/l
2.28
566
5258
101
743
1.43
2.61
2.4
2.5
104.14
107.21
ug/g
0.03
71
602
93
674
1.44
2.61
1.4
1.3
—
—
—
0
0
31
171
1.85
2.59
1.4
1.2
—
2.17
—
0
15
45
278
1.67
2.57
2.1
2.1
0.00
2.82
estimate
0.51
17
90
6
11
5.49
2.55
4.0
2.5
0.55
0.62
mmol/l
—
6
11
24
122
2.00
2.53
1.5
1.7
4.16
4.30
iu/l
—
8
46
19
88
2.19
2.53
1.1
1.0
1.41
2.26
u/ml
—
9
39
19
89
2.17
2.47
4.2
3.8
2.04
2.61
mmol/l
0.43
14
59
10
32
3.16
2.44
1.6
2.9
732.80
1370.34
u/ml
—
10
32
172
1394
1.32
2.43
5.8
4.3
—
—
—
0
0
9
27
3.37
2.40
3.6
1.3
17.73
31.95
umol/l
—
9
22
292
2539
1.27
2.40
3.8
2.7
—
—
estimate
—
0
0
20
97
2.10
2.39
1.1
1.1
0.14
0.81
u/ml
—
7
39
23
118
1.98
2.38
1.1
1.1
0.60
2.73
u/ml
—
9
61
25
133
1.92
2.34
2.4
2.8
1.50
2.47
index
0.32
12
77
25
133
1.92
2.34
3.6
4.2
8.19
8.16
kpa
0.03
25
133
254
2176
1.28
2.34
2.0
2.1
—
—
—
0
0
67
468
1.48
2.28
7.2
3.8
7.38
7.39
ph
0.38
41
258
8
24
3.36
2.18
1.0
1.1
—
—
—
0
0
20
102
1.99
2.12
1.1
1.1
—
—
—
0
0
20
102
1.99
2.12
1.1
1.0
0.79
5.14
u/ml
—
8
50
45
294
1.57
2.09
4.6
6.5
—
—
—
0
0
20
103
1.97
2.07
1.1
1.0
—
—
—
0
0
6
15
4.03
2.04
1.0
2.7
41.52
41.42
g/l
—
6
15
8
26
3.10
2.02
1.0
1.0
—
—
—
0
0
8
26
3.10
2.02
1.0
1.2
162.65
137.86
iu/ml
—
8
26
26
148
1.79
2.01
1.7
3.6
1.46
2.26
ratio
0.90
13
89
16
78
2.08
1.92
1.3
1.3
30.66
26.01
u/l
0.18
16
69
13
58
2.27
1.92
1.1
1.3
256.18
317.35
mu/l
0.70
13
49
21
114
1.87
1.89
3.7
4.9
62.44
64.18
%
0.10
21
114
12
52
2.33
1.88
2.5
3.3
1.52
3.06
nmol/l
3.02
12
52
16
79
2.05
1.86
1.1
1.2
—
—
—
0
0
37
238
1.59
1.86
3.9
4.0
—
—
—
0
0
48
328
1.50
1.85
1.1
1.1
—
—
—
0
0
58
413
1.44
1.83
13.6
9.9
—
—
—
0
0
21
116
1.84
1.80
3.4
2.1
139.31
129.61
g/l
0.72
16
96
69
509
1.40
1.80
2.8
5.2
2.96
29.48
ug/l
1.02
56
416
13
60
2.19
1.78
1.5
1.4
—
—
—
0
0
60
433
1.43
1.77
1.2
1.2
—
—
—
0
0
7
24
2.94
1.72
1.3
1.2
0.00
0.00
estimate
—
7
24
6
19
3.18
1.66
1.2
1.1
—
—
—
0
0
6
19
3.18
1.66
1.0
1.0
—
—
—
0
0
62
456
1.40
1.65
8.2
3.7
2.28
1.93
mmol/l
0.26
55
393
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
114
922
1.29
1.62
4.0
3.4
834.87
515.94
ng/l
0.19
76
671
29
183
1.61
1.60
1.3
1.4
251.12
208.58
miu/ml
—
10
89
92
725
1.31
1.59
1.9
1.5
—
—
—
0
0
6
20
3.02
1.58
2.0
1.3
1.72
2.21
umol/l
—
6
15
7
26
2.71
1.58
1.1
4.7
15.44
15.99
%
—
7
26
30
192
1.59
1.57
1.8
2.8
—
—
—
0
0
33
219
1.53
1.49
2.3
1.9
2.02
3.31
ug/l
0.37
33
196
19
111
1.73
1.40
1.6
4.6
—
—
—
0
0
17
96
1.79
1.40
1.1
1.1
5.80
1.77
u/ml
—
7
42
27
174
1.58
1.39
3.9
2.0
230.58
7098.87
u/l
1.64
12
67
71
551
1.32
1.38
1.6
1.8
3.31
3.52
mmol/l
0.89
45
388
40
282
1.45
1.37
1.7
1.7
—
—
—
0
0
22
135
1.65
1.37
1.3
1.2
—
—
—
0
0
101
823
1.27
1.37
3.2
2.9
3.56
1.88
e6/l
0.67
48
407
64
490
1.34
1.36
5.5
2.5
32.42
128.63
u/l
0.50
48
425
18
105
1.73
1.34
2.6
3.6
—
—
—
0
0
10
47
2.15
1.34
2.2
1.2
129.20
112.57
pmol/l
—
10
47
6
24
2.51
1.30
1.8
1.7
0.67
1.95
u/field
—
6
19
85
683
1.28
1.29
8.0
7.7
103.65
104.71
mmol/l
1.10
85
683
8
34
2.37
1.29
1.1
1.3
—
—
—
0
0
5
18
2.79
1.28
7.6
4.8
—
—
—
0
0
11
55
2.02
1.28
1.1
1.1
—
—
—
0
0
8
35
2.30
1.27
1.6
2.4
938.25
1364.74
mg
—
8
35
97
797
1.26
1.24
2.2
2.1
—
—
—
0
0
10
50
2.02
1.17
1.3
1.1
—
—
—
0
0
5
20
2.51
1.15
1.0
1.7
—
49.58
—
0
12
10
51
1.98
1.11
1.3
1.2
—
—
—
0
0
9
165
0.54
1.09
7.1
9.8
—
—
—
0
0
11
59
1.88
1.08
5.0
2.4
1103.91
1127.10
e6/l
0.03
11
52
182
1617
1.17
1.05
7.8
5.8
—
—
—
0
0
9
46
1.97
1.04
1.3
1.0
—
—
—
0
0
5
22
2.28
1.03
3.8
1.7
36.60
32.36
%
—
5
22
18
114
1.60
1.03
1.6
1.6
—
—
—
0
0
9
47
1.93
1.02
5.3
2.7
329.00
226.32
e6/l
—
9
41
39
291
1.36
1.02
1.3
1.2
—
—
—
0
0
26
181
1.45
1.00
1.9
4.0
615.09
205.05
mg/l
0.51
11
83
27
190
1.44
0.98
1.4
2.1
21.95
20.65
s
0.77
21
171
63
507
1.27
0.98
2.2
2.0
0.00
0.03
estimate
0.50
18
111
49
383
1.30
0.95
1.2
1.2
—
—
—
0
0
11
62
1.79
0.94
1.1
1.3
—
—
—
0
0
620
6102
1.40
0.90
38.7
20.8
235.99
248.65
e9/l
5.46
608
6001
55
679
0.79
0.89
1.4
1.5
—
—
—
0
0
6
29
2.08
0.89
1.3
3.8
8.12
8.17
mmol/l
—
6
29
620
6103
1.39
0.89
38.6
20.7
93.46
90.93
fl
30.79
615
6045
620
6104
1.39
0.88
39.5
21.3
41.69
41.06
%
2.17
615
6041
620
6104
1.39
0.88
38.6
20.7
31.57
30.36
pg
42.39
615
6046
620
6104
1.39
0.88
38.7
20.8
4.52
4.57
e12/l
1.48
606
5981
238
2185
1.14
0.87
4.5
5.1
1.89
2.28
ug/l
0.73
216
1993
620
6105
1.39
0.87
38.8
20.8
6.33
6.60
e9/l
3.13
606
5981
8
45
1.79
0.84
5.4
2.5
416.25
438.62
e6/l
—
8
37
8
45
1.79
0.84
3.0
7.5
11.80
11.00
%
—
8
45
620
6107
1.38
0.84
38.9
20.9
141.41
137.95
g/l
5.70
615
6049
18
121
1.50
0.83
1.2
1.7
—
—
—
0
0
8
47
1.71
0.81
2.0
1.3
83.88
78.23
umol/l
—
8
47
8
47
1.71
0.81
3.3
2.3
32.24
37.40
%
—
8
47
18
122
1.49
0.81
1.1
1.3
2.22
34.55
e6/l
—
9
91
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
7.37
—
0
14
73
615
1.21
0.78
1.7
1.5
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
1554.83
1503.18
miu/ml
—
6
34
36
280
1.30
0.76
3.6
3.0
1.25
1.34
%
0.17
36
280
18
124
1.46
0.75
1.1
1.4
78.00
1073.56
e6/l
0.56
11
97
9
54
1.68
0.74
1.2
1.5
269.38
343.33
pmol/l
—
9
54
5
24
2.09
0.74
1.0
1.1
—
24.18
—
0
5
25
186
1.36
0.71
1.6
1.6
45.72
10.53
u/ml
—
6
52
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
148
1341
1.13
0.66
3.0
3.1
0.75
0.71
ug/l
0.20
84
830
12
78
1.55
0.66
1.3
1.1
—
—
—
0
0
11
70
1.58
0.65
2.4
2.5
—
—
—
0
0
5
29
1.73
0.64
2.2
1.4
65.80
100.32
ng/l
—
5
29
14
96
1.47
0.62
1.4
1.2
6.67
3.89
u/ml
—
6
44
25
192
1.31
0.60
4.2
4.1
24.64
24.74
mmol/l
0.10
25
185
8
54
1.49
0.57
1.8
2.1
—
—
—
0
0
180
1668
1.11
0.55
1.6
1.4
—
—
—
0
0
51
436
1.18
0.51
2.6
2.1
0.76
0.34
e6/l
0.41
51
418
6
41
1.47
0.50
1.5
1.4
—
—
—
0
0
34
280
1.23
0.50
3.5
3.0
0.57
0.63
%
0.69
34
280
29
235
1.25
0.49
2.7
2.2
—
—
—
0
0
7
47
1.49
0.47
1.1
1.2
—
—
—
0
0
7
48
1.46
0.47
1.4
2.1
—
—
—
0
0
8
118
0.67
0.46
1.6
1.6
—
—
—
0
0
19
148
1.29
0.44
1.1
1.2
—
—
—
0
0
11
78
1.42
0.43
1.3
1.2
—
—
—
0
0
20
158
1.27
0.42
1.5
1.6
—
—
—
0
0
5
33
1.52
0.41
9.2
3.3
34.90
15.05
mu/l
—
5
33
0
15
0.00
0.41
0.0
2.0
—
17.26
—
0
15
7
103
0.68
0.39
2.4
1.6
—
—
—
0
0
20
160
1.26
0.39
1.1
1.1
—
—
—
0
0
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
13
98
1.33
0.37
1.1
1.2
—
—
—
0
0
8
114
0.70
0.37
1.5
1.5
—
—
—
0
0
9
70
1.29
0.36
1.8
1.5
—
—
—
0
0
51
452
1.14
0.35
2.3
2.2
5.81
6.10
ph
1.31
24
294
36
415
0.86
0.35
3.7
3.0
—
—
—
0
0
11
82
1.35
0.34
2.9
2.5
—
—
—
0
0
7
52
1.35
0.31
1.3
1.3
6.74
6.51
mmol/l
—
7
46
28
240
1.17
0.30
1.4
1.5
—
—
—
0
0
123
1308
0.93
0.30
3.6
3.4
1.02
1.02
kg/l
0.09
84
853
21
250
0.83
0.30
1.1
1.1
1.46
1.53
g/l
0.62
21
250
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
15
120
1.26
0.30
1.1
1.4
—
—
—
0
0
28
241
1.17
0.29
1.4
1.5
—
—
—
0
0
28
242
1.16
0.28
1.4
1.5
—
—
—
0
0
10
77
1.30
0.26
4.3
2.3
—
—
—
0
0
27
238
1.14
0.22
1.4
1.5
—
—
—
0
0
19
220
0.86
0.21
1.8
1.7
—
—
—
0
0
5
42
1.19
0.21
3.6
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
44.68
—
0
10
0
10
0.00
0.21
0.0
1.1
—
0.21
—
0
5
0
10
0.00
0.21
0.0
1.2
—
0.43
—
0
10
0
10
0.00
0.21
0.0
1.5
—
68.90
—
0
10
0
10
0.00
0.21
0.0
1.0
—
22.40
—
0
5
0
12
0.00
0.21
0.0
7.7
—
10.17
—
0
12
0
12
0.00
0.21
0.0
3.8
—
37.08
—
0
12
6
48
1.25
0.20
1.3
1.2
1.05
1.44
nmol/l
—
6
42
6
48
1.25
0.20
2.0
2.1
1.19
1.19
mmol/l
—
6
48
0
14
0.00
0.20
0.0
2.8
—
30.55
—
0
8
6
49
1.23
0.20
2.0
2.1
4.18
3.98
mmol/l
—
6
49
6
49
1.23
0.20
2.0
2.1
105.50
105.41
mmol/l
—
6
49
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
10
82
1.22
0.17
2.4
1.5
—
—
—
0
0
10
82
1.22
0.17
2.4
1.5
—
—
—
0
0
10
82
1.22
0.17
2.4
1.5
—
—
—
0
0
10
82
1.22
0.17
2.4
1.5
—
—
—
0
0
51
545
0.93
0.16
2.0
1.8
—
—
—
0
0
11
130
0.84
0.16
1.7
1.1
—
—
—
0
0
11
130
0.84
0.16
1.7
1.1
—
—
—
0
0
8
73
1.10
0.15
1.9
2.3
—
—
—
0
0
23
255
0.90
0.15
1.4
1.2
0.90
0.91
g/l
0.02
23
255
9
80
1.13
0.15
1.3
1.1
—
—
—
0
0
24
218
1.10
0.13
1.4
1.5
—
—
—
0
0
24
223
1.08
0.09
1.2
1.1
—
—
—
0
0
122
1249
0.97
0.08
3.7
3.5
—
0.00
—
0
10
17
163
1.04
0.01
18.1
1.7
—
—
—
0
0
13
124
1.05
0.00
1.5
1.9
—
—
—
0
0
13
127
1.02
0.00
1.3
1.3
—
—
—
0
0
13
131
0.99
0.00
1.6
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
0.03
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
62
0.97
-0.00
1.3
2.0
13.17
10.40
mmol/l
—
6
62
0
7
0.00
-0.00
0.0
1.0
—
17.09
—
0
7
5
51
0.98
-0.00
2.8
1.1
—
—
—
0
0
6
60
1.00
-0.00
1.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.3
1.8
—
—
—
0
0
5
50
1.00
-0.00
1.6
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_IRON_MET and mortality.

Females

Parameter HR [95% CI] p-value
E4_IRON_MET 1.819 [1.37, 2.42] < 0.001
Birth year 0.997 [0.99, 1.01] 0.43

During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 700 females with E4_IRON_MET died.

Males

Parameter HR [95% CI] p-value
E4_IRON_MET 2.068 [1.7, 2.51] < 0.001
Birth year 0.988 [0.98, 1.0] 0.012

During the follow-up period (1.1.1998 — 31.12.2019), 233 out of 1047 males with E4_IRON_MET died.

Mortality risk

Mortality risk for people of age

years, who have E4_IRON_MET.

N-year risk Females Males
1 0.185% 0.41%
5 1.129% 2.443%
10 2.835% 6.134%
15 5.252% 11.96%
20 8.954% 19.321%

Relationships between endpoints

↥

Index endpoint: E4_IRON_MET – Disorders of iron metabolism

GWS hits: 6

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data